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ABSTRACT
MARTIN AARON NEWMAN:  THE REGULATION OF LET-7 MICRORNA 
BIOGENESIS IN EMBRYONIC DEVELOPMENT 
(Under the direction of Scott Hammond)
 microRNAs (miRNAs) are small non-protein-coding RNAs that silence gene 
expression post-transcriptionally and have critical functions in development, tissue 
homeostasis and in the pathogenesis of many diseases.  They carry out gene silencing 
by targeting complementary sequences in messenger RNAs (mRNAs) in the context of 
a ribonucleoprotein particle named RISC (for RNA induced silencing complex).  The 
mature miRNA contained within RISC is a ~21 nucleotide single stranded RNA that must 
be processed in two RNase III-catalyzed reactions.  In animals, our precise understanding 
of miRNA funtion in vivo has been hindered by the fact that animal miRNAs do not 
basepair with perfect complementarity to their miRNA targets.  However, much insight 
into miRNA function has been gained by the study of their spatio-temporal expression.  
Of particular interest is that the majority of known mouse miRNAs are not detectable 
during early embryogenesis but are robustly induced in later in gestation, during the time 
of tissue differentiation.  Intriguingly, there is a broad down regulation of miRNAs in 
poorly differentiated tumors; thus it is a critical long-term goal to understand whether the 
global absence of miRNAs in cancer reflects the reversion to an embryonic-like cellular 
state.  Studies described herein show that the abundance of many miRNAs, including the 
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let-7 family of tumor suppressor miRNAs, are regulated post-transcriptionally both in 
murine development and in cancer.  Furthermore, RNase III-mediated processing of let-7 
is blocked by the embryonic stem (ES) cell-specific RNA binding protein Lin28.   While 
the exact mechanism of the Lin28-mediated processing block is not known, a popular 
model predicts that Lin28 binds to the short hairpin precursor let-7 (pre-let-7) and 
recruits the terminal uridyl transferase, TUT4, leading to oligo-uridylation and turnover 
of pre-let-7.  Directly testing this hypothesis is technically challenging, in part, because 
short-hairpin miRNA precursors (pre-miRNAs) are low in abundance.  We developed 
a novel and powerful technique to detect pre-miRNAs utilizing high-throughput DNA 
sequencing.  Unexpectedly, we observed that pre-let-7 is uridylated in differentiated cells, 
which lack Lin28; furthermore, many pre-miRNAs are uridylated in vivo, likely through 
a Lin-28-independent pathway.
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CHAPTER 1:  
INTRODUCTION
 In 1993, two research groups discovered that the gene lin-4, in the roundworm 
Caenorhabditis elegans (C. elegans), encoded a small RNA that could bind to 
complementary sites in the lin-14 messenger RNA (mRNA), thereby regulating Lin-14 
protein abundance during embryonic development (R. C. Lee, Feinbaum, & Ambros, 1993; 
Wightman, Ha, & Ruvkun, 1993).  The idea that a small non-protein-coding RNA (ncRNA) 
could post-transcriptionally regulate gene expression was unprecedented and so, for several 
years, the lin-4 ncRNA seemed like an odd outlier in molecular biology.  RNA-mediated 
gene silencing gained wide attention in 1998 when Andrew Fire, Craig Mello and colleagues 
described the phenomenon of RNA interference (or RNAi): the injection of double-stranded 
RNA (dsRNA) into C. elegans could silence the expression of a gene whose nucleotide 
sequence matched that of the dsRNA (Fire et al., 1998).  The discoveries of RNAi and the 
lin-4 RNA, at first, seemed unrelated.  However, in 1999, another landmark study showed 
that small RNAs were the molecular determinant of post-transcriptional gene silencing 
(PTGS) in plants.   It soon became clear that RNAi did not just occur with RNA from an 
external source, but that the cellular machinery responsible for RNAi employed a broad 
spectrum of genomically-encoded, small ncRNAs; the first class of these small RNAs to be 
characterized was microRNA (miRNA); lin-4 is considered to be the “founding” miRNA.  
To date, a diverse collection of small ncRNA pathways have been discovered beyond 
the miRNA pathway; in all known cases, small RNAs guide sequence-specific changes in 
gene expression at either the transcriptional or post-transcriptional level.  In plants, small 
RNA pathways act, in part, as a primitive immune system, processing viral RNAs into short-
2interfering RNAs (siRNAs); plants also contain their own complement of genes that encode 
miRNAs.  Small RNA pathways in animals prevent the mobilization of transposon elements 
(piRNAs), modulate chromatin modifications (siRNAs) and carry out post-transcriptional 
gene silencing (endo-siRNAs and miRNAs, Figure 1.1; for a thorough review see, (Ghildiyal 
& Zamore, 2009)).  
 While endogenous small RNA pathways are instrumental in diverse biological 
processes, they share two common characteristics: 1) each small RNA pathway utilizes a 
class of small single-stranded RNA (ssRNA) that must be processed from larger dsRNA 
precursor molecules (an exception is piRNAs, whose precursor’s are thought to be ssRNA); 
2) each class of small ssRNA associates with a member of the PIWI/Argonaute (Ago) 
pathway of proteins.  PIWI/Ago proteins contain 3 unique functional domains (Figure 1.1A). 
The PAZ domain is located near the N-terminus and accommodates the 3’end of the small 
RNA.  The MID domain binds to the small RNA’s phosphorylated 5’ end.  The PIWI domain 
possesses an RNase H-like activity that mediates cleavage of target RNAs to which the small 
RNA is bound (Farazi, Juranek, & Tuschl, 2008).  
 For reasons that are still not entirely clear, the endogenous RNAi pathways in certain 
organisms are more numerous than in others.  For instance, the C. elegans genome encodes 
an exceptionally large number of PIWI/Ago genes (Simard and Hutvagner NRMCB, 2008); 
they even possess a clade of secondary-siRNA-interacting Agos (or “Sagos”) that exist only 
in worms.  These Sagos facilitate the amplification of the initial RNAi response.  Small RNA 
effector complexes are named differently depending on the class of small RNA and the PIWI/
Ago protein that are complexed together ((Farazi et al., 2008; Ghildiyal & Zamore, 2009) 
Figure 1.1B). 
The basic mechanism of miRNA-mediated gene silencing: 
 miRNAs are 18-25 nucleotide (nt) ssRNAs that associate with Ago proteins to form 
an RNA induced silencing complex (or RISC).  The miRNA mediates RISC-binding to 
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Figure 1.1: Small RNA effector complexes and the mechanism of miRNA-mediated silencing.  A) Sche-
matic of the domain organization of a representative PIWI/Ago family protein, Piwi from the prokaryote 
Aquifex aeolicus (cartoon adapted from Farazi et al., Development 2008).  B) Simplified diagrams of diverse 
small RNA effector complexes.  C) Simplified diagram of the mechanism of miRNA mediated gene silenc-
ing.  The initial repression of mRNA translation occurs in the cytosol, after which the miRISC bound to 
targeted mRNA localizes to large cytosolic aggregates called P-bodies.  Ribosomes are depicted as white 
ovals.  Poly-A binding protein 1 (PABP1) is depicted as the small yellow ovals.
4cognate sequences in mRNAs to beget post-transcriptional gene silencing.  In mammals, 
there are 4 Ago proteins, Ago1-4; Ago2 is unique because it is the only Ago protein with the 
amino acid residues within its PIWI domain necessary for RNase-H-like catalysis (Farazi 
et al., 2008).  In the case of exogenously-introduced siRNAs (e.g. transfected into cultured 
mammalian cells by a researcher), the extensive base-pairing of an siRNA RISC (bound to 
Ago2) with its target mRNA allows cleavage of the mRNA at a position corresponding to the 
region between the 10th and 11th nucleotides of the siRNA (Martinez et al., 2002).  In contrast, 
miRNA-containing RISCs (or miRISCs) bind with less extensive complementarity to the 
target mRNA, usually within its 3’ untranslated region (3’ UTR).  This results in translational 
repression and/or mRNA destabilization through a complex series of events. 
 While the exact mechanism of miRNA-mediated silencing is, to date, intensely 
debated, it is sufficient here to describe a model where the binding of miRISC to a target 
mRNA ultimately leads to its translational repression, de-adenylation of the mRNA and, 
often times, decreased mRNA abundance.  It is believed that translational repression 
occurs in the cytosol whereupon miRISC-targeted mRNAs are sequestered to mRNA 
processing bodies in the cytosol called “P-bodies.”  P-bodies are thought to exclude the 
general translation machinery from miRNA-targeted mRNAs as well as to mediate mRNA 
degradation.  mRNA decay in P-bodies requires Ago proteins, the Ago-associated protein 
GW182, the decapping enzyme DCP2, additional decapping activating factors and the CAF1-
CCR4-NOT deadenylase complex (Figure 1.1C, (Eulalio et al., 2008)).  
microRNA biogenesis:
 The small single-stranded miRNAs that associate with Ago proteins are the 
biologically active triggers of the miRNA pathway.  However, these “mature” miRNAs 
are initially generated as longer dsRNA precursors that must be processed in a series of 
RNase-mediated events.  The miRNA biogenesis pathway is particularly well-characterized; 
mammalian miRNA biogenesis is depicted in Figure 1.2 and is explained in detail below (for 
5detailed review see (V. N. Kim, Han, & Siomi, 2009).  In the simplest sense, miRNAs are 
processed from larger precursor RNAs by two RNaseIII-catalyzed cleavage events followed 
by unwinding of the resulting duplex and incorporation of the single-stranded mature miRNA 
into RISC.  
miRNA genes are transcribed by RNA polymerase (pol) II or III giving rise to a primary 
microRNA transcript (pri-microRNA).  Pol II-generated pri-microRNAs (which are better-
characterized) exist within introns and exons of non-coding transcripts as well as within 
introns of protein-coding transcripts; accordingly they have been shown experimentally to be 
capped and poly-adenylated (Cai et al., 2004).  Recent bioinformatic analyses have revealed 
that a majority of microRNAs are intronic; furthermore, a significant portion (estimated up 
to 42%) of microRNAs exist in polycistrons containing two or more microRNA precusors 
(Altuvia et al., 2005).
Pri-microRNA processing by the Drosha/Dgcr8 complex:  
 The first major step forward in understanding the biochemical basis of microRNA 
processing was a study by V. Narry Kim and colleagues.  They demonstrated that pri-miRNA 
transcripts generated in vitro could be processed to a distinct ~70nt product in nuclear 
extracts, approximately the size of a short hairpin precursor miRNA (pre-miRNA); this 
was, the first demonstration of an in vitro pri-miRNA processing assay.  They next verified 
that this RNA product was a bona fide pre-miRNA by subsequently adding cytoplasmic 
extract, resulting in appearance of mature miRNA (Y. Lee et al., 2002); as the RNase III 
enzyme Dicer was already known to process pre-miRNAs in to mature miRNAs (Hutvagner 
et al., 2001; Knight & Bass, 2001), this study illustrated that miRNA maturation requires 
two unique RNA processing events.  To identify the enzyme responsible for pri-miRNA 
processing, it was first determined that the 5’ and 3’ ends of the pre-miRNA generated in 
vitro were characteristic of RNase III cleavage: the pre-miRNA contained a 2nt, 3’ overhang 
(Y. Lee et al., 2003).  As pri-miRNA processing occurs in the nucleus and only one human 
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Figure 1.2: The miRNA biogenesis pathway.  miRNA genes can be intergenic or situated with 
protein-coding genes and, in both cases, can be intronic or exonic.  Transcription by either RNA pol II 
or pol III (depending on the miRNA gene) yields a pri-miRNA that is processed by the Microprocessor 
complex (containing Drosha and Dgcr8) into a pre-miRNA; in the case of mirtrons, pre-miRNAs 
generation circumnavigates the Drosha step and is created by splicing and debranching of a small 
intron.  The pre-miRNA is then exported to the cytosol where it is further processed by Dicer into a 
mature miRNA duplex, from which (usually) one strand will be loaded in to an Ago protein to beget a 
miRISC.
7RNase III protein, Drosha, occupies the nuclear compartment, it became clear that Drosha 
was enzyme responsible for pri-miRNA cleavage (Y. Lee et al., 2003).  
 Pri-miRNAs form a characteristic stemloop structure that is critical for processing 
by Drosha; the stemloop consists of an approximately 30 basepair (bp) stemloop region, an 
unstructured terminal loop ranging in size from approximately 10-30nts and flanked on either 
side by unstructured ssRNA.  The Drosha enzyme alone is not sufficient for pri-microRNA 
processing in vitro but requires the dsRNA-binding domain (dsRBD) protein DeGeorge 
critical region 8 (Dgcr8, called Pasha in invertebrates;(Denli et al., 2004; Gregory et al., 
2004).  An elegant in vitro study demonstrated that Dgcr8 recognizes the dsRNA-ssRNA 
junction of pri-microRNAs; in UV-crosslinking studies, Dgcr8 had detectable pri-miRNA 
binding activity whereas Drosha did not.  This led to the hypothesis that Dgcr8 mediates 
recognition of  pri-microRNAs by Drosha, which then cleaves ~11bp above the ssRNA-
dsRNA junction, liberating the pre-miRNA (Han et al., 2006). Several studies recently 
reported that pri-microRNA processing may occur co-transcriptionally (Y. K. Kim & Kim, 
2007; Morlando et al., 2008; Pawlicki & Steitz, 2008).  Drosha cleavage does not reduce 
splicing efficiency of an intron in vivo (Y. K. Kim & Kim, 2007).  Furthermore, pri-miRNAs 
are tightly associated with chromatin (Morlando et al., 2008; Pawlicki & Steitz, 2008); also, 
in fluorescence microscopy experiments pri-miRNAs and Drosha localize to site of Pol II 
transcription (Pawlicki & Steitz, 2008).  Taken together, this data suggests that transcription 
and Drosha cleavage are tightly coupled processes.
 Fractionation of Drosha and Dgcr8 by size-exclusion chromatography suggested 
the proteins are associated in small (~250 kilo-Dalton [kDa]) and large (>2 mega-Dalton 
[MDa]) molecular weight complexes.  Both of these complexes are referred to as the 
“Microprocessor” but they differ in protein composition.  The small complex is composed 
solely of Drosha and Dgcr8 whereas the large complex contains many additional, abundant 
RNA-binding proteins.  These additional “auxillary factors” have diverse roles in cellular 
RNA metabolism (e.g. splicing, mRNA stability, etc…Gregory et al., 2004) although, to date, 
8most do not have an assigned function in the context of the Microprocessor.
Dicer processing and RISC loading:
 The pre-miRNA molecule which results from Drosha cleavage is a short hairpin RNA 
with a 5’ phosphate group, a 3’ hydroxyl group and a 3’ 2nt overhang.  The terminus of the 
pre-miRNA is recognized by exportin-5 and the pre-miRNA is exported to the cytosol in a 
Ran-GTP-dependent manner (Bohnsack et al., 2004; Lund et al., 2004; Yi et al., 2003).  Once 
in the cytosol, the pre-miRNA encounters the cytosolic RNaseIII Dicer, which clips off the 
precursor loop yielding a microRNA duplex.  Several biochemical studies showed that Dicer 
exists in a complex with the dsRBD protein TRBP and an Ago protein; this allows “Dicing” 
of the precursor, unwinding of the microRNA duplex and loading of the mature microRNA 
strand into RISC to occur in a concerted series of events ((Chendrimada et al., 2005; Gregory 
et al., 2005; Maniataki & Mourelatos, 2005); Figure 1.2).
 Aside from the conventional biogenesis pathway, certain pre-miRNAs arise from 
splicing of a small intron rather than from pri-miRNA cleavage by Drosha (Ghildiyal & 
Zamore, 2009), Figure 1.2).  These “miRtrons” have been detected in invertabrates as well 
as vertebrates, perhaps suggesting that the differences between the miRNA and miRtron 
processing pathways may confer important functional differences between their resulting 
mature miRNA products.  
The biological function of miRNAs:
 The discovery of miRNAs was built upon pioneering studies in C. elegans, where 
two “founding” miRNAs, lin-4 and let-7 were characterized as critical non-protein-coding 
genes in early and late embryonic development, respectively(R. C. Lee et al., 1993; Reinhart 
et al., 2000; Wightman et al., 1993).   Worm embryos mutant for the lin-4 gene displayed 
precociously differentiated larval tissue whereas let-7 mutants exhibited a failure of certain 
cell lineages to differentiate, resulting in a vulval bursting phenotype.  miRNAs are now 
9recognized as important components of gene expression circuitry and have crucial roles in 
normal developmental as well as in the pathogenesis of many diseases including cancer.  
Thus, the overall function of miRNAs in vivo is currently a subject of intense study.
 An effective approach to understanding miRNA biological function has been to 
identify natural mutations or to design targeted knockouts of miRNA genomic loci.  For 
example, a key study revealed that the copy-number of a genomic locus harboring the 
miR-17-92 polycistronic cluster is amplified in many cancers (L. He et al., 2005), making 
miR-17-92 the first known miRNA oncogene (also the original group of miRNAs referred 
to an “oncomiR”).  Conversely, a locus that contains the miR-15a and miR-16-1 genes is 
frequently deleted in B-cell chronic lymphocytic leukemia (Calin et al., 2002), revealing 
the function of these miRNAs as tumor suppressors.  In an example of targeted deletion, 
transgenic mice lacking miR-1-2 showed severe defects in the development of cardiac 
precursor cells despite the fact that one miR-1 locus was unmodified (Zhao et al., 2007).  
This study not only attributed a role for miR-1 in cardiogenesis but also revealed that the 
proper dosage of a miRNA can be critical for proper development.  Depsite being an effective 
tool for understanding miRNA function in vivo, genetic manipulation of miRNAs may not 
feasible for all miRNAs; for instance, total disruption of let-7 miRNA function would require 
targeted knockout of 12 genomic loci.  In a related approach, total miRNA expression in 
embryonic stem (ES) cells was ablated by the targeted deletion of the Dgcr8 gene (Wang et 
al., 2007); these ES cells were viable but were unable to differentiate implicating a role for 
microRNAs in shutting down stem cell self-renewal programs.
 An ideal approach in understanding miRNA function would be to identify the 
comprehensive set mRNAs targets for a given miRNA.  This has been a monumental 
challenge in the field because, in animals, miRNAs bind with imperfect complimentarity to 
mRNAs making bioinformatic analysis of mRNA targets very difficult (reviewed in (Bartel, 
2009)).  One consistent finding has been the clear requirement for a miRNA “seed match,” 
in which a stretch of nucleotides in the mRNA perfectly corresponds to nucleotides 2-8 of 
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the miRNA (this seed match can vary between 7-8 nucleotides of complementarity; for an 
extensive review (Bartel, 2009)).  To date, rules for the contribution of the remainder of the 
miRNA in basepairing to its target mRNA have not been experimentally established (Bartel, 
2009).  Clearly it will be important to employ novel methods in the identification of miRNA 
targets as bioinformatic approaches suggest that more than half of the human protein-coding 
genome may be targeted by miRNAs (Bartel, 2009).  Indeed, one potentially powerful 
alternative technique in the miRNA target identification is the use of dual-label mass 
spectrometry to directly analyze cellular protein compositioin after depletion of a selected 
miRNA (Baek et al., 2008; Selbach et al., 2008).
 Understanding miRNA function is even further complicated by the recent idea (and 
observation) that the direct outcome of a miRNA binding to certain targets might simply 
be the sequestration (or “sponging up”) of miRNAs without affecting the expression levels 
of the bound target (Seitz, 2009).  This hypothesis is supported by a recent study where 
pseudogene transcripts of PTEN and KRAS compete with their protein-coding mRNA 
counterparts for miRNA binding, thereby controlling PTEN and K-Ras protein levels 
(Poliseno et al., 2010).  
 Intensive efforts in analyzing miRNA experession patterns have significantly 
contributed to our understanding of the biological function of miRNAs.  Initial studies to 
detect mature miRNAs utilized northern blot analysis in various tissues and at different 
developmental stages (R. C. Lee et al., 1993; Reinhart et al., 2000; Sempere et al., 2004).  
Subsequently, miRNA microarray platforms were developed which greatly expedited 
expression analysis of the rapidly growing catalog of known miRNAs in various organisms 
(Thomson et al., 2004).  More recently, high-throughput or “deep-sequencing” technology 
has given miRNA researchers an immensely powerful tool in the detection of both abundant 
and rare miRNAs as well as in the identification of novel miRNA genes (Hafner et al., 2008). 
 Research in miRNA detection over nearly the past decade has culminated in the 
classification of miRNA expression patterns during development and in the pathogenesis 
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of many diseases.  For example the pattern of miRNA expression during murine embryonic 
development generally falls into three categories and is illustrated in Figure 1.3A.  In 
embryonic stem (ES) cells and in very early embryonic development, most miRNAs are not 
detectable save for the “early embryonic” miRNAs (which include the miR-302 and miR-290 
families); it is now known that these miRNAs help to maintain the unique cell-cycle of ES-
cells which contributes to ES-cell self renewal (Wang et al., 2008).  Conversely, the majority 
of known miRNAs are robustly induced later in development, during tissue formation and 
throughout the remainder of life.  This differentiation-specific cohort includes not only 
tissue-restricted miRNAs, such as miR-124 in the brain, miR-1 and miR-133 in the heart 
and skeletal muscle and miR-122 in the liver but also more widely-expressed miRNAs such 
as the let-7 and miR-30 families.  Last, expression of the miR-17-92 polycistron and related 
miRNAs is continuous throughout development although these miRNAs are more abundant 
early on. 
 Expression profiling has also been widely used to create miRNA “signatures” for 
many diseases, especially in cancer research.  This is best exemplified in a seminal study that 
employed a bead-based fluorescence assay to compare miRNA levels in hundreds of different 
tumor samples with those found in normal tissue(J. Lu et al., 2005).  Amazingly, the miRNA 
signatures in various cancers faithfully reflected their tissue origin; furthermore, using 
miRNA profiles to identify the origin of poorly differentiated tumors was more effective 
than using mRNA expression data.  Most intriguingly, this study revealed that there is a 
widespread down-regulation of mature miRNAs in many types cancer; this global absence of 
miRNAs is reminiscent of miRNA expression in early embryogenesis (Figure 1.3B).  Thus, 
it is tempting to speculate that one overall function of the miRNA pathway is to maintain the 
differentiated state of adult tissues.
Initial evidence for the post-transcriptional regulation of miRNA biogenesis: 
 Many early studies of miRNA expression contributed provided insight into the 
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potential functions of miRNAs in vivo.  However, what was largely underappreciated 
for some time was the possibility that miRNA abundance is controlled not only at the 
level of transcription but that post-transcriptional mechanism could be involved.  Over 
the past several years, many studies have made it clear that miRNA abundance is often 
post-transcriptionally regulated, suggesting that the precise spatio-temporal control of 
miRNA expression is crucial for normal cell function.  One of the earliest indications of 
post-transcriptional regulation was the subtle observation that pri-let-7a-1 is detectable 
in both differentiated and undifferentiated ES cells by reverse transcription followed 
by polymerase chain reaction (RT-PCR,  (Suh et al., 2004)); this presented an exciting 
scenario where mature let-7a did not accumulate possibly due to a block of Dicer or Drosha 
processing.  Another interesting report demonstrated that pre-miR-138-2 was ubiquitously 
expressed in mouse tissues but the corresponding mature miRNA is restricted to only 
certain compartments by late embryogenesis; this was first evidence that some miRNAs 
might be blocked at the point of Dicer cleavage (Obernosterer et al., 2006).   Furthermore, 
an intriguing study of breast cancer samples found dysregulation of ceratin genes encoding 
miRNA biogenesis machinery, providing a partial explanation for the broad down-regulation 
of miRNA abundance in cancer(Blenkiron et al., 2007).  
 miRNA levels are post-transcriptionally regulated not only during miRNA processing 
but also at the point of mature miRNA turnover.  Mendell and colleagues first observed that 
miR-29 abundance was regulated by a novel mechanism in human cell culture that involved 
nuclear import of mature miR-29, possibly followed by its degradation (Hwang, Wentzel, 
& Mendell, 2007).  A recent report in C. elegans revealed that mature miRNA turnover by 
the exonuclease XRN-2 is coupled to RISC loading in vitro and that the mature miRNA is 
protected from turnover when annealed to a target RNA (Chatterjee & Grosshans, 2009).  
Two somewhat related discoveries showed that the degradation of a miRNA is dependent on 
the extent to which it is base paired with its target RNA (Ameres et al., 2010; Cazalla, Yario, 
& Steitz, 2010).  An equally interesting study revealed that certain miRNAs in photoreceptor 
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Figure 1.3: miRNA expression patterns.  A) A generalized view of miRNA expression patterns during 
murine embryonic development.  B) miRNA expression heat map from a key study (Lu et al., Nature. 
2005 Jun 9;435(7043): 834-8) where hundreds of different tumors were profiled for miRNA expression 
versus corresponding normal tissue.  This experiment was the first to indicate that there is a global down-
regualtion of miRNA abundance in cancer.
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cells of the retina, as well as in certain neurons are rapidly turned over (Krol et al., 2010).  
Taken together, there is a broad spectrum of biochemical mechanisms by which miRNA 
expression is post-transcriptionally regulated.
The let-7 family of miRNAs: 
 let-7 is an ancient and highly conserved miRNA, likely existing in most, if not all 
bilaterian animals (Christodoulou et al., 2010).   While simpler organisms such as flies and 
worms possess only one let-7 miRNA gene, vertebrate genomes encode an expanded family 
of closely related let-7 genes.  For example, mice and humans have 12 let-7 genes that 
encode a total of 9 mature miRNAs (Figure 1.4).  let-7 was the second of the two “founding” 
miRNAs discovered by the Ruvkun lab in 2000 (Reinhart et al., 2000).  While function of 
this miRNA family isn’t exactly understood, it exhibits similar expression patterns in diverse 
animals and is generally associated with cell differentiation.  In C. elegans let-7 was first 
found to target critical heterochronic genes such as lin-41, lin-14 and lin-28 (Reinhart et 
al., 2000); in mammals, let-7 miRNAs target a variety of oncogenes such as Ras, HMGA2, 
Myc, Cdc25a and Cdk6 (Bussing, Slack, & Grosshans, 2008).  These findings have further 
revealed the function of let-7 miRNAs as tumor suppressors.  Consistent with this notion, 
mature Let-7 is down regulated in many cancers and is most depleted in poorly differentiated 
tumors (Shell et al., 2007).  
Lin28:
 Lin28 is an ES-cell specific RNA binding protein that was originally identified in 
C. elegans as a heterochronic gene (Ambros & Horvitz, 1984); mutations in the lin-28 
gene caused precocious differentiation of many cell lineages implicating lin-28 as a critical 
regulator of early development in the worm.  It was later discerned that lin-28 encodes an 
RNA binding protein with a cold-shock domain (CSD) and 2 CCHC zinc finger motifs, 
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Figure 1.4: Genomic organization of the let-7 family of miRNAs in mice.  Distances between miRNA stemloops are 
not drawn to scale.  (-) and (+) denotes the chromosome strand from which the pri-miRNA transcript originates.  White, 
labeled boxes denote exons of a protein coding transcript.
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Lin28:
 Lin28 is an ES-cell specific RNA binding protein that was originally identified in 
C. elegans as a heterochronic gene (Ambros & Horvitz, 1984); mutations in the lin-28 
gene caused precocious differentiation of many cell lineages implicating lin-28 as a critical 
regulator of early development in the worm.  It was later discerned that lin-28 encodes an 
RNA binding protein with a cold-shock domain (CSD) and 2 CCHC zinc finger motifs, 
a unique domain architecture among known proteins (Moss, Lee, & Ambros, 1997b); 
furthermore, lin-28 mRNA is targeted in its 3’ UTR by the lin-4 and let-7 miRNAs (Moss, 
Lee, & Ambros, 1997b; Reinhart et al., 2000).  Several studies in mammalian cell culture 
revealed that the Lin28 protein associates with actively translated mRNA and promotes the 
translation of the IGF-2 mRNA suggesting it functions, in part, in the post-transcriptional 
regulation of genes in undifferentiated cells (Balzer & Moss, 2007; Polesskaya et al., 2007).  
Mammals possess two separate genes that encode to homologs of the C. elegans lin-28, 
Lin28a and Lin28b.  Interestingly, not only does Lin28 play an important biological role in 
undifferentiated cells but also Lin28b is overexpressed in hepatocellular carcinoma (HCC), 
implicating mammalian Lin28a and Lin28b as potential oncoproteins (Guo et al., 2006).  
Amazingly, the ectopic expression of the lin28a gene in combination with several other ES-
cell-specific factors causes “reprogramming” of somatic cells into induced pluripotent stem 
(iPS) cells (Yu et al., 2007).
Non-canonical poly (A) polymerases and the modulation of RNA stability and activity: 
 As some of the research described in this dissertation focuses on the uridylation 
of pre-miRNAs, it is worth discussing terminal uridyl transferases (or TUTases) here.  
TUTases are part of a diverse family of RNA-specific ribonucleotidyl transferase enzymes 
(Martin & Keller, 2007) which also includes the canonical Poly (A) polymerases (or P(A)
Ps) found in animals that add a long tail of adenosines to mature mRNAs (Wilusz & Wilusz, 
2008).  The TUTases (sometimes, confusingly, called non-canonical P(A)Ps) differ from 
17
the canonical P(A)Ps in that they add shorter stretches of adenosines or uridines to specific 
RNAs, depending on the TUTase (Wilusz & Wilusz, 2008).  While little is known about the 
cellular function of these enzymes, they have been implicated in diverse processes, including 
U6 snRNA recycling (Trippe et al., 2006), histone mRNA degradation (Mullen & Marzluff, 
2008), the uridylation of miRNA-mediated cleavage products in diverse organisms (Shen & 
Goodman, 2004) as well as in the stabilization of miR-122 (Katoh et al., 2009).  Intriguingly, 
a recent study by Bartel and colleagues G&D (2010) revealed that many miRNA 3’ strands 
(“3p” or “star” strands) possess 3’ terminal untemplated uridines, possibly indicating the 
widespread uridylation of pre-miRNAs (Chiang et al., 2010).
CHAPTER 2:
Extensive post-transcriptional regulation of microRNAs and its implications for 
cancer1.
Summary:
 MicroRNAs (miRNAs) are short, non-coding RNAs that post-transcriptionally 
regulate gene expression.  While hundreds of mammalian miRNA genes have been identified, 
little is known about the pathways that regulate the production of active miRNA species.  
Here we show that a large fraction of miRNA genes are regulated post-transcriptionally.  
During early mouse development, many miRNA primary transcripts, including the let-7 
family, are present at high levels but are not processed by the enzyme Drosha.  An analysis of 
gene expression in primary tumors indicates that the widespread down-regulation of miRNAs 
observed in cancer is due to a failure at the Drosha processing step. This data uncovers a 
novel regulatory step in miRNA function, and provides a mechanism for miRNA down-
regulation in cancer.
Introduction:
 The founding miRNA, lin-4, was discovered more than 20 years ago in the nematode 
Caenorhabditis elegans (R. C. Lee et al., 1993).  Elegant studies demonstrated that the 
gene product of lin-4 was a non-coding RNA that post-transcriptionally regulated several 
critical genes during development (Wightman et al., 1993).  More recently a large number 
of miRNA genes have been identified in plant and animal genomes.  To date over 300 
1  Reprinted from Thomson et al., Genes Dev. 2006 Aug 15;20(16):2202-7 with permission from Cold Spring Harbor Press.  This manuscript has been formatted for the dissertation.
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miRNAs have been validated in the human genome, and computational predictions suggest 
that many hundreds more exist (Aravin & Tuschl, 2005). While it is clear that these small, 
non-coding RNAs have essential functions in mammalian biology, few miRNA genes have 
been functionally linked to specific cellular pathways.  For example, miR-181 modulates 
hematopoietic differentiation, and miR-1 and miR-133 participate in skeletal and cardiac 
muscle development.  The polycistronic cluster miR-17~92 promotes lymphomagenesis, 
while let-7 suppresses proliferation by targeting the oncogene Ras (see Wienholds & 
Plasterk, 2005 for a review).
 For most miRNA genes, however, biological information is limited to expression 
analyses.  In mouse and zebrafish, few miRNAs are expressed in early embryos (Thomson, 
Parker, Perou, & Hammond, 2004b; Wienholds et al., 2005).  During mid to late embryonic 
development, large numbers of miRNAs are induced in temporal and spatial patterns 
(Kloosterman, Wienholds et al., 2006).  This culminates in adult tissues, where a large 
fraction of known miRNA genes are expressed.  Interestingly, most of these same miRNA 
genes are down-regulated in cancer, perhaps reflecting a loss of cellular differentiation (J. Lu 
et al., 2005; Takamizawa et al., 2004).  The regulatory mechanism behind these expression 
changes is largely unknown, though the most obvious candidate is transcriptional control.  
It is difficult, however, to reconcile this model with the widespread, parallel reduction in 
miRNA expression observed in most types of human cancer.
 A second possibility is that miRNA maturation is a regulated event.  The biogenesis 
of miRNAs begins with a primary transcript, termed the pri-miRNA, which is generated 
by RNA polymerase II (V. N. Kim, 2005).  The active species is contained in a stem-loop 
structure which is liberated by the nuclear ribonuclease III (RNase III) Drosha.  This stem 
loop, termed the pre-miRNA or precursor, is exported from the nucleus in a Ran/GTP/
Exportin 5 mediated event.  In the cytoplasm, the precursor is further processed by the 
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RNAseIII enzyme Dicer to generate the mature miRNA species.  In a concerted reaction, 
this siRNA-like product is loaded into the RNA induced silencing complex (RISC) where it 
mediates target mRNA translational suppression (Du & Zamore, 2005; Gregory et al., 2005; 
Maniataki & Mourelatos, 2005).
 In principal, any step during this maturation process could be regulated.  The core 
enzymes are widely expressed, however, and no post-translational regulation of Drosha or 
Dicer has been reported.  Discrepancies between the levels of primary transcript, precursor, 
and mature miRNA species have been reported, however no clear model is apparent (Eis et 
al., 2005; Suh et al., 2004).  Here we report that a large fraction of miRNAs are regulated 
during the Drosha processing step, and this regulation has a major impact on miRNA 
expression during embryonic development and in cancer.
Results and Discussion:
 A striking event during mouse development is the massive induction of Let-7 family 
miRNAs at approximately 10.5 days of gestation.  This is exemplified by Let-7g.  This 
miRNA is housed in the second intron of the WD40 repeat gene AK037620 (Figure 2.1A).  
Processing of this primary transcript by Drosha yields a 79 nucleotide stem-loop precursor.  
Further processing by Dicer leads to the 21 nucleotide mature species.  We analyzed the 
expression of all three molecular forms by northern blotting (Figure 2.1B).  As previously 
reported, mature Let-7g is undetectable in embryonic stem (ES) cells and P19 embryonal 
teratocarcinoma cells (Thomson et al., 2004).  Expression is detectable at 10.5 day gestation 
and is high at 14.5 day.  The precursor is detectable slightly earlier than the mature miRNA, 
suggesting a delay at the Dicer processing step.  Similar results have been observed in mouse 
and Drosophila development (Hutvagner et al., 2001; Schulman, Esquela-Kerscher, & Slack, 
2005).  Surprisingly, the primary transcript is highly expressed throughout development, with 
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Figure 2.1.  Expression of let-7g during mouse development (These experiments were carried out by 
J. Michael Thomson).  (A)  The genomic organization of Let-7g is shown.  RT-PCR primer sites are 
indicated by arrows.  Primer Ex1 and Ex2 were used for PCR of the primary transcript.  Primer Ex1 and In1 
were used for PCR of the unspliced primary transcript. (B) Northern blot analysis of the molecular species 
of Let-7g.  18S rRNA and U6 snRNA were used for loading controls for pri-miRNA and pre-
miRNA/mature, respectively.  (C) Non-quantitative RT-PCR of the unspliced primary transcript.  Control 
reactions without the reverse transcription step are shown.  (D) Non-quantitative RT-PCR of the let-7g 
primary transcript and mature species.  The U6-snRNA reference is also shown.  Right lanes are control 
reactions without reverse transcription step. (E)  Real-time RT-PCR analysis of let-7g primary transcript 
and mature species.  Reactions were performed in triplicate and normalized to U6 cycle threshold values.  
Expression is shown as relative values on a logarithmic scale.
J. M. Thomsom
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little difference in expression between ES cells and 14.5 day embryos.  This discrepancy is 
not resolved by the amount of unspliced pri-miRNA, since this is also essentially constant 
(Figure 2.1C).
 We next quantitated the levels of primary and mature species by real time RT-PCR.  
We adapted a published procedure to measure the amount of both species from a single 
reverse transcription (RT) reaction (Shi & Chiang, 2005).  (see Supplemental Figures 1 and 
2 for validation; Figure 2.1D illustrates a non-quantitative example).  U6 snRNA was used 
for normalization for mature and primary species.  This RNA exhibited more consistent 
expression during embryonic development than more typical reference RNAs such as beta-2 
microglobulin, glyceraldehyde-3-phosphate dehydrogenase, and beta-glucuronidase.  Using 
this procedure, we determined that the amount of mature let-7g increases 4200 fold between 
ES cells and 14.5 day embryo.  As observed by Northern blot analysis, expression levels of 
the primary transcript does not match the mature miRNA, but is relatively constant (Figure 
2.1E, note log scale).  
 There are several possible explanations for the different expression levels of the 
pri-miRNA and the mature miRNA.  There could be rapid turnover of the mature species 
in ES cells compared to late embryos.  This is unlikely, since mature miRNAs from other 
gene families are present in ES cells (e.g. miR-290~295), and published data suggests 
that all miRNAs are loaded into RISC complexes non-discriminately (Liu et al., 2004).  A 
second possibility is that the precursor for let-7g is retained in the nucleus, or otherwise 
made inaccessible to Dicer.  In that circumstance we would expect to see an accumulation 
of precursor.  Our data disagrees with this, since the precursor is essentially undetectable in 
ES cells.  A third possibility, most congruous with our data, is that processing of let-7g is 
blocked at the Drosha step.  Release of the block would enable production of mature let-7g.  
It is worth emphasizing that this is not simply a delay in processing during development, but 
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a complete block.  ES cells are grown continuously in culture, express high levels of let-7g 
primary transcript, and never process a significant quantity to the precursor or mature species. 
 We next investigated processing of other miRNA genes that are expressed during 
development (Figure 2.2).  Let-7 family miRNAs are located at eight genomic loci 
(Griffiths-Jones et al., 2006).  Of these we were able to detect primary transcripts for four 
loci.  Notable is the let-7f-2/ miR-98 cistron, which is located within an intron of the widely 
expressed ubiquitin ligase gene HUWE-1.  All four primary transcripts were expressed at 
similar levels throughout development.  Similar to let-7g, all mature miRNAs within these 
genes were elevated several thousand fold between ES cells and 14.5 day gestation.  The 
correlation between primary transcript expression and mature miRNA expression was close 
to zero, with the exception of let-7i (see Table 2.1).  For this miRNA, the primary transcript 
is induced during development, though there is still a large difference in processing efficiency 
(300 fold, Table 2.1).  Two of the four let-7 clusters we analyzed were intronic, and two were 
exonic.  Thus there is no correlation between regulated processing by Drosha and intron/exon 
location.  
 This Drosha regulatory step has not been observed in other organisms.  C. elegans 
let-7, for example, is induced at the fourth larval stage and continues into the adult.  
Expression is controlled by defined enhancer elements in the promoter of the primary 
transcript (Johnson, Lin, & Slack, 2003a).  Expression of the primary transcript is closely 
correlated with mature let-7 (Bracht et al., 2004).
 The developmental function of let-7 family members in mammals is not known.  
There have been reports of decreased let-7 expression in primary tumors (J. Lu et al., 2005; 
Takamizawa et al., 2004).  This may have functional consequences.  The oncogene Ras is a 
validated target of let-7 (Johnson et al., 2005).  Thus, decreased let-7 expression would lead 
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Figure 2.2.  miRNA expression during mouse development (These experiments were carried out by J. 
Michael Thomson).  The expression levels of primary transcript and mature species from 12 representative 
miRNAs are shown. Red bars represent mature miRNA and blue bars represent primary transcript.  All 
analyses are performed with the following RNA samples, from left to right: P19 teratocarcinoma cell line; 
embryonic stem cell line; 10.5 day gestation mouse embryo; 14.5 day gestation mouse embryo.  Reactions 
were performed in triplicate and normalized to U6 cycle threshold values.  Expression is shown as relative 
values on a logarithmic scale.  The bold font indicates the mature miRNA gene that was used for RT-PCR 
analysis.  In all cases these are unique miRNA sequences in the mouse genome.
J. M. Thomsom
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to increased Ras expression, which would promote survival of tumor cells.  Our data raises 
the possibility that let-7 down-regulation in tumors is post-transcriptional (see below).
 Several other families of miRNAs are up-regulated during mouse development.  We 
were able to detect primary transcripts for nine of these miRNAs.  Most cases exhibited 
regulated Drosha processing (Figure 2.2, Table 2.1).  Exceptions were miR-21 and the 
miR-143/miR-145 cluster.  Both primary transcripts matched expression of the mature 
species (correlation = 1.0 and 0.99, respectively).  Another interesting example is the miR-15/
miR-16 cistron, which is located at two genomic loci.  Each primary transcript displays 
distinct expression kinetics.  The chromosome 14 copy is located within an uncharacterized 
gene which is induced during development.  The chromosome 3 copy, in contrast, is located 
within the condensin subunit SMC4L1 which is constitutively expressed.  Thus, each pri-
miRNA contributes to the mature species in a complex manner, with a post-transcriptionally 
regulated component (chromosome 3) and a transcriptionally regulated component 
(chromosome 14).  
 It should be noted that coordinate expression of the primary transcript and the mature 
miRNA does not prove that Drosha processing is not regulated.  Such miRNAs (bottom 
panel, Table 1) may be regulated at transcription and Drosha processing.  It remains a 
possibility that all miRNAs are regulated at the Drosha step, except for miRNAs that have 
demonstrated expression in the early mouse embryo.  Interestingly, this has implications 
for experiments that utilize ectopic expression of miRNAs in ES cells.  We predict that this 
would fail to produce the mature species, unless cis-regulatory elements were removed from 
the expression cassette.
 Our data suggests that the differentiation events that occur during embryonic 
development activate Drosha processing of specific miRNAs.  To directly test this we used 
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let-7g +0.29 5400
let-7f-2/miR-98 -0.12 2700
let-7i +1.00 300
let-7d/let-7a-1/let-7f-1 -0.21 1400
miR-140 -0.20 290
miR-23b/miR-24-2/miR-27b -0.29 110
miR-30b/miR-30d +0.89 2.5
miR-103-1 -0.38 18
miR-103-2 -0.87 120
miR-15b/miR-16-2 -0.68 19
miR-15a/miR-16-1 +0.98 0.23
miR-21 +0.99 1.4
miR-143/miR-145 +0.99 9.3
            miRNA gene                                         pri-miRNA/mature                         D processing 
                                                                                     correlation                                   efficiency
Table 2.1.  Expression correlation for mature/pri-miRNA pairs (this analysis was carried 
out by J. Michael Thomson and Scott Hammond).  Pearson correlations were calculated for 
each mature miRNA/pri-miRNA pair and are shown in the first column.  The change in 
processing efficiency is defined as the ratio of mature to pri-miRNA in 14.5 day embryo 
divided by the ratio of mature to pri-miRNA in ES cells, and is shown in the right column.  
The table is divided into miRNAs regulated by Drosha (top) and miRNAs potentially unregu-
lated by Drosha (bottom).
J.M. Thsomson and S.M. Hammond
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the teratocarcinoma cell line P19, which can be differentiated in culture into multiple cell 
types (Rudnicki et al., 1990).  miRNA microarray expression analysis of untreated and 
differentiated P19 cells mirrors the expression changes observed during mouse development 
(data not shown).  Embryonic miRNAs, such as the miR-290~295 cluster, are down-
regulated during differentiation.  In contrast, miRNAs that are up-regulated during mouse 
development, including let-7 family members, are increased upon differentiation.  As in 
embryonic development, the increases in let-7 miRNAs are not coupled to transcription of 
the pri-miRNA (see Figure 2.3).  
 One experimental observation of cancer cells is the widespread alterations in 
miRNA expression.  While some miRNAs are elevated, for example the oncogenic cluster 
miR-17~92, most miRNAs have significantly reduced expression (L. He et al., 2005; J. Lu 
et al., 2005).  Our data raises the possibility that these reductions are a consequence of the 
Drosha processing block.  To address this we analyzed existing expression data, comparing 
mature miRNA levels with the primary transcript.  The most complete data set, from the 
Broad Institute, has Affymetrix mRNA expression data and Luminex miRNA data from a 
wide range of primary tumors and normal tissues (J. Lu et al., 2005; Ramaswamy et al., 
2001).  We combined the data set in the following manner:  68 tumors and 21 normal tissue 
samples had data for miRNA and mRNA expression.  Of 217 miRNAs, 22 could be mapped 
to a primary transcript that was present on the Affymetrix microarray.  When this restricted 
miRNA dataset was hierarchically clustered, the normal samples were located in a single 
node with some tumor samples, while most tumors clustered in a separate node (Figure 
2.4A).  The tumor samples had overall reduction in miRNA expression levels.  This was 
qualitatively similar to the entire miRNA expression map, as previously published (J. Lu et 
al., 2005).  
 We then created an expression map of primary transcript expression levels (Figure 
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Figure 2.3.  miRNA expression during P19 cell differentiation.  P19 teratocarcinoma cells were 
differentiated by forming embryoid bodies for four days in the presence of all-trans retinoic acid (RA), 
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mature miRNA species were quantitated by real-time RT-PCR. Reactions were performed in triplicate 
and normalized to U6 cycle threshold values.  Expression is shown as relative values on a linear scale.  
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2.4A).  The samples and genes are arranged in the same order as for the miRNA expression 
map.  The high and low clusters of expression are completely lost in the primary transcript 
expression map.  We performed correlation analysis between each mature/pri-miRNA 
expression pair, for each sample.  The data is represented in the histogram in Figure 
2.4B.  There is no correlation between pri-miRNA and mature expression in the tumor 
samples, while the normal tissue samples had positive correlation (KS test, p < 0.01).  This 
demonstrates that the miRNA alterations that occur in tumors, for this limited set of genes, 
are not due to mis-regulated transcription.
 Our data suggests a multistep model for the control of miRNA expression.  
Transcription of the pri-miRNA can be regulated, as has been demonstrated for tissue specific 
miRNAs (J. F. Chen et al., 2006; Fazi et al., 2005; O’Donnell et al., 2005; Zhao, Samal, & 
Srivastava, 2005).  Processing at the Dicer step can be delayed or inhibited (Hutvagner et 
al., 2001; Obernosterer et al., 2006; Schulman et al., 2005).  We demonstrate that further 
suppression of miRNA production is achieved at the Drosha step.  This may be necessary 
for early development, where inappropriate expression of even small amounts of let-7 may 
promote differentiation, with disastrous consequences.  This model also allows miRNAs to 
be located in essential housekeeping genes that are ubiquitously expressed.
 The biochemical nature of Drosha regulation is unknown.  We measured the 
expression levels of Drosha and its binding partner DGCR8, during the P19 differentiation 
time course (Supplemental Figure 3).  No induction occurred concordant with the production 
of mature miRNAs.  It is possible these proteins are regulated by post-translational 
modification.  Alternatively, additional regulatory binding proteins may be required for 
specific miRNA processing.  Recently, adensosine deaminase (ADAR) editing of specific 
pri-miRNAs has been reported (W. Yang et al., 2006).  This editing event leads to decreased 
processing of the miRNA by Drosha and increased turnover by the Tudor-SN nuclease.  We 
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Figure 2.4.  miRNA expression in primary tumors (This data analysis was carried out by Scott Hammond 
and Joel Parker).  (A) Normalized miRNA expression data from (Lu et al. 2005) was clustered hierarchically in 
both dimensions and is displayed as an expression map.  Yellow indicates increased expression and blue indicates 
decreased expression, relative to the median.  Primary transcript expression data from (Ramaswamy et al. 2001) 
was mapped in the same order as the mature miRNA expression map.  Mature miRNA/primary transcript gene 
pairs are indicated on the right.  Tumor samples are indicated in red and normal tissues indicated in black. (B)  
Pearson correlation values for each mature/pri-miRNA value pair were calculated.  Values for normal samples 
(dashed line) and tumor samples (solid line) are plotted as a histogram.  
S.M. Hammond
and Joel Parker
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tested whether this mechanism is responsible for the Drosha block during embryogenesis.  
We failed to find evidence of A-I editing of let-7 pri-miRNAs in ES cells (not shown).  Our 
data does not, however, discount the possibility of other structural changes in the pri-miRNA 
that block processing.  An alternative mechanism is the sequestration of regulated pri-
miRNAs away from the processing apparatus.  The exact nature of the regulatory mechanism 
awaits further investigation.  
Materials and Methods.
Cell lines.
 The feederless ES cell line E14Tg2A.4 was grown on gelatin-coated plates in 
Glasgow MEM (Sigma) supplemented with 2 mM glutamine, 1 mM pyruvate, 1X non-
essential amino acids, 15% fetal bovine serum (Hyclone), 0.1 mM b-mercaptoethanol, and 
103 units/ml leukocyte inhibitory factor (Chemicon).  The P19 teratocarcinoma cell line was 
grown in DMEM (Sigma) supplemented with 7.5% calf serum (Hyclone) and 2.5% fetal 
bovine serum.  P19 cells were differentiated as follows: Cells were seeded on non-adhesive 
plates in a-MEM (Sigma) supplemented with 5% fetal bovine serum and 500 nM all-trans 
retinoic acid (Sigma).  After four days the aggregated cells were plated on standard tissue 
culture dishes in DMEM supplemented with 7.5% calf serum and 2.5% fetal bovine serum, 
and grown for the indicated number of days.  
RNA isolation
 Dissected whole embryos from pregnant CD1 mice were flash frozen in liquid 
nitrogen and pulverized into powder. Total RNA was extracted from pooled embryos of two 
to eight embryos or from cell lines with Trizol Reagent (Invitrogen, Carlsbad, CA, USA) 
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according to manufacturer’s instructions. 
Northern blot analysis of mRNA
 5 µg total RNA was resolved on a 1% agarose formaldehyde gel and transferred 
overnight to positively charged nylon membrane by capillary transfer with 10X SSC. The 
membrane was washed briefly in 2X SSC, dried, and UV cross-linked, and incubated 
overnight with 107 cpm of a random-primed probe directed against the mouse Let-7g 
primary transcript in Church and Gilbert high stringency buffer.  PCR primers specific for 
the mouse Let-7g primary transcript (let-7g-probe-F 5’-TTTAGTCCCAATGGCGAGAC-3’; 
let-7g-probe-R 5’-CATCACCACACCCTTGAATG-3’) were used to make the probe. The 
membrane was washed 1 x 15 min at 420C in 2X SSC, 0.1% SDS and then 2 x 15 min 650C 
in 0.2X SSC, 0.1% SDS. Phosphorimaging using the Storm system (Molecular Dynamics) 
revealed the let-7g primary transcript. The size of pri-Let-7g (3.7 kb) was confirmed against 
18S and 28S rRNA markers.  The size of pre-Let-7g was confirmed against an in vitro 
transcribed pre-Let-7g RNA.   All primers were purchased from MWG Biotech (Highpoint, 
NC, USA).
Northern blot analysis of pre-miRNA and mature miRNA
 5 ug total RNA was resolved on 15% (mature) or 7.5%(precursor) acrylamide-8M 
urea-TAE gels as described previously (Hammond, Bernstein, Beach, & Hannon, 2000).  
After electroblotting to Hybond N+ membranes, blots were probed with an end-labeled 
Locked Nucleic Acid (LNA) probe ACTgTaCaAaCtAcTaCcTcA (small letters are LNA, caps 
are DNA).  Hybridization was performed in Church and Gilbert high stringency buffer at 65 
C, followed by 3 washes in 0.1X SSC at 65 C.
Quantitative RT-PCR
 Total RNA, 20 µg, was DNase I (Promega, Madison, WI, USA) treated according 
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to manufacturer’s instructions, phenol:chloroform extracted, ethanol precipitated and 
dissolved in DEPC-treated dH2O. RNA, 10µg, was polyadenylated using Poly(A) polymerase 
(Ambion) according to manufacturer’s instructions, phenol:chloroform extracted, ethanol 
precipitated and dissolved in DEPC-treated dH20. A modified cDNA was made as follows; 10 
µg of polyadenylated RNA was reverse transcribed using Superscript II reverse transcriptase 
(Invitrogen, Carlsbad, CA, USA) using 2.5 ug random hexamers and 500 ng oligo-dT adapter 
primer (5’- GCGAGCACAGAATTAATACGACTCACTATAGGTTTTTTTTTTTTVN-3’) 
according to manufacturers instructions. The reaction was terminated by incubation at 700C 
for 10 min and diluted into 2 ml dH2O (5 µg/ml). Quantitative PCR was used to measure 
both the mature miRNA and the host mRNA transcript as follows; 5 µl cDNA was mixed 
with 5 pmol of both the forward and reverse primers in a final volume of 12.5 µl and mixed 
with 12.5 µl of 2x SYBR® Green PCR master mix (Applied Biosystems) . Primer sequences 
and other pri-miRNA information is in Supplemental Table 1.  All reactions were run in 
triplicate on a DNA Engine Opticon® 2 (MJ Research) utilizing two amplification protocols. 
A standard protocol was performed for the pri-miRNA PCR, 20 s at 940C, 30 s at 590C 
and 20 s at 720C for 40 cycles. Mature miRNA PCR was performed according to the high-
stringency protocol of (Shi and Chiang 2005) except the reverse primer Mir-qPCR-3-3’ (5’- 
GCGAGCACAGAATTAATACGACTCAC
 -3’) was used in conjunction with an exact sequence-specific primer to each miRNA. 
Mature and pri-miRNA expression both utilized the reference gene U6 snRNA (U6-F 
5’-CGCTTCGGCAGCACATATAC-3’ and U6-R 5’-TTCACGAATTTGCGTGTCAT-3’). 
Expression was calculated using the formula 2-∆CT, with ∆CT = (CT miRNA - CT reference 
RNA) for mature miRNA or ∆CT = (CT pri-miRNA - CT reference RNA) for pri-miRNA. 
Non-quantitative PCR conditions for the Let-7g pri-miRNA and mature miRNA, and U6 
reference gene were as mentioned above, except the cycle number was 40, 35, and 30 
respectively. The same conditions were performed on an equal amount of DNAse I-treated 
RNA as a negative control. Reactions, 5 µl, were resolved by electrophoresis on 12% native 
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polyacrylamide TBE gels and stained with ethidium bromide.  Unspliced pri-miRNA was 
analyzed by RT-PCR at 50 cycles.  The same conditions were performed on an equal amount 
of DNAse I-treated RNA as a negative control.  For analysis of Drosha, DGCR-8, and Oct-4, 
qRT-PCR was performed similarly, using b2-macroglobulin as a reference RNA.
Microarray gene expression analysis.
 Normalized, log transformed expression data was downloaded from http://www.
broad.mit.edu/cgi-bin/cancer/datasets.cgi.  89 samples were common to the miRNA and 
mRNA datasets.  22 miRNA/pri-miRNA pairs were found in the combined data sets.  This 
reduced set of miRNA data was median centered by gene and hierarchically clustered in both 
dimensions using Cluster software (Stanford University).  An expression map was generated 
using Treeview software (Stanford University).  The pri-miRNA data set was arranged in 
the same order as the miRNA clustered data, median centered by gene, and a non-clustered 
expression map was generated.  Pearson correlation of normalized, log transformed 
intensities was calculated for each mature/pri-miRNA pair.  Pairwise correlations were 
tabulated across tumor or normal samples, and a smoothed histogram was generated.
Chapter 3: 
Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA 
processing2
Summary
 A hallmark of mammalian embryonic development is the widespread induction of 
microRNA (miRNA) expression.  Surprisingly, the transcription of many of these small, 
noncoding RNAs is unchanged through development; rather, a post-transcriptional regulatory 
event prevents accumulation of the mature miRNA species.  Here we present a biochemical 
framework for the regulated production of the Let-7 family of miRNAs.  Embryonic cells 
contain a Drosha Inhibitor that prevents processing of the Let-7 primary transcript.  This 
inhibitor specifically binds to conserved nucleotides in the loop region of the Let-7 precursor, 
and competitor RNAs that mimic the binding site restore Let-7 processing.  We have 
identified the Drosha Inhibitor as the embryonic stem cell specific protein Lin-28.  Lin-28 has 
been previously implicated in developmental regulatory pathways in Caenorhabditis elegans, 
and promotes reprogramming of human somatic cells into pluripotent stem cells.  Our 
findings outline a microRNA post-transcriptional regulatory network and establish a novel 
role for the miRNA precursor loop in the regulated production of mature Let-7.  
Introduction:
2  Reprinted from Newman et al., RNA. 2008 Aug;14(8):1539-49 with permission from Cold Spring Harbor Press.  This manuscript has been reformatted for the disserta-tion.
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 It is now generally appreciated that diverse forms of double stranded RNA (dsRNA) 
can act as triggers of RNA interference (RNAi) or related homology dependent gene 
silencing pathways (Chapman & Carrington, 2007).  Among these triggers are microRNAs 
(miRNAs), which are single stranded but fold into stable stem-loop structures, providing the 
essential double stranded feature.  miRNAs are encoded in the genomes of most metazoans 
and function in a post-transcriptional layer of gene regulation (see (Bartel, 2004) for a 
review).
 The founding miRNA, lin-4, was discovered in C. elegans as a mutant that displayed 
heterochronic, or developmental timing defects (R. C. Lee et al., 1993; Wightman et al., 
1993).  The activity of this small RNA is mediated largely through repression of two well 
established target mRNAs, lin-14 and lin-28 (Ambros, 1989).  A second miRNA, let-7, was 
later identified as a heterochronic mutant (Reinhart et al., 2000).  Surprisingly, this miRNA 
has complete nucleotide conservation from C. elegans to humans, suggesting an ancient 
biological role (Pasquinelli et al., 2000).  More recently, thousands of miRNAs have been 
identified across many phyla.  While few validated mRNA targets have been assigned to 
these miRNAs, computational predictions suggest that each miRNA has tens to hundreds of 
targets, underscoring their immense potential for controlling gene expression (Bartel, 2004).
 The initiation of miRNA dependent gene regulation is the transcription of a primary 
transcript, or pri-miRNA (see (V. N. Kim, 2005) for a review).  This RNA is typically 
thousands of nucleotides long and is often capped, spliced, and poly-adenylated.  The stem-
loop structure is excised by the ribonuclease enzyme Drosha, liberating the precursor, or pre-
miRNA.  After export out of the nucleus, the precursor is further processed by the enzyme 
Dicer.  The resultant siRNA-like molecule is loaded into the RNAi effector complex RISC, 
where it directs nucleolytic degradation and translational repression of target mRNAs.
 While hundreds of miRNAs have been identified in the human and mouse genomes, 
the biological role of most miRNAs is unknown.  However, numerous studies have linked 
miRNA function to the regulation of cell growth and differentiation (see (Esquela-Kerscher 
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& Slack, 2006) for a review).  For example, the miRNA cluster miR-17-92 is highly 
expressed in a wide range of cancers, and ectopic expression of this candidate oncogene 
promotes cancer in several mouse models.  This miRNA cluster is also highly expressed in 
early mouse development, and at least one study has confirmed its role in preventing the 
differentiation of progenitor cells (Y. Lu et al., 2007).  In contrast to these “oncomiRs”, a 
large number of miRNAs, including the Let-7 family, is depleted in cancer.  Let-7 itself has 
been shown to target the oncogenes Ras, Myc, and HMGA2, and expression of this miRNA 
inversely correlates with disease severity (Esquela-Kerscher & Slack, 2006; Y. S. Lee & 
Dutta, 2007; Mayr, Hemann, & Bartel, 2007).  Interestingly, global downregulation of all 
miRNAs promoted disease in a mouse model for lung carcinoma, suggesting that the overall 
tumor-suppressive functions of miRNAs are more important than oncogenic functions of, for 
example, miR-17-92 (Kumar, Lu, Mercer, Golub, & Jacks, 2007).
Results:
Regulated microRNA biogenesis:
 The widespread alterations in miRNA expression in cancer prompted us to investigate 
the regulatory mechanisms responsible for their production.  Our initial studies focused on 
the Let-7 family, where we previously demonstrated that induction of this miRNA family 
during mouse embryogenesis occurs at a post-transcriptional stage (Thomson et al., 2006).  
Since we observed a large amount of primary transcript in the absence of precursor and 
mature species, we predicted that a block was in place at the Drosha endonuclease processing 
step.  We tested this directly using an established cell-free assay that reports Drosha activity 
(Y. Lee et al., 2002).  We compared the processing efficiency of a regulated miRNA, Let-
7g, with a miRNA that is readily processed in all known cell types, miR-17.  We incubated 
radiolabeled primary transcripts for these miRNAs in nuclear extracts prepared from the 
mouse embryonal carcinoma cell line P19.  We had previously shown that this cell line 
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exhibits regulated processing of Let-7, as it has abundant pri-Let-7 but no detectable mature 
Let-7 (Thomson et al., 2006).  As a control we performed assays in extracts derived from 
Hela cells, which have abundant mature Let-7, thus are competent for Let-7 processing.  
Nuclear extracts derived from Hela cells were efficient at processing both Let-7g and 
miR-17, with approximately equal amounts of each precursor product being generated 
(Figure 3.1).  While several RNA species are generated after the Drosha reaction, we were 
able to confirm the identity of the correct precursor reaction products by Northern blot 
hybridization of unlabeled products (Supplemental Figure 1).  
 While the control nuclear extract was competent for both Let-7g and miR-17 
processing, extracts derived from undifferentiated P19 cells were inefficient at processing 
Let-7g (Figure 3.1).  We calculated the ratio of Let-7g product to miR-17 product to generate 
a Let-7 processing efficiency.  Undifferentiated P19 cells were ~10 fold less efficient at 
processing Let-7g compared to miR-17.    
 This data demonstrates that Drosha processing of Let-7 is less efficient in embryonic 
cells, but it does not discriminate between an activator present in the Hela extract or an 
inhibitor present in the P19 extract.  Therefore we performed the same assay in a 1:1 mixed 
extract of P19 and Hela cells.  The mixed extract assay yielded product ratios similar to 
the P19 extract alone, indicating that the regulatory factor is dominant in P19 cells and is 
therefore an inhibitor of Let-7 processing (Figure 3.1).  To rule out the possibility that the 
regulatory event was due to the modification of Drosha itself, we immunoprecipitated the 
Drosha protein from undifferentiated P19 nuclear extracts.  This purified protein was no 
longer subject to regulated processing as it was fully competent for Let-7 processing (Figure 
3.1).  
 While our data demonstrates a regulatory point at the Drosha processing step, it does 
not preclude regulation at other steps in miRNA biogenesis.  Specifically, regulation of Let-7 
biogenesis at the Dicer processing step has been reported (Wulczyn et al., 2007).
microRNA regulatory sequences:
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 Since Drosha protein that had been immunopurified had lost the regulatory factor, 
the most logical conclusion of our data was that a Drosha Inhibitor, present in the P19 
extract, was interacting directly with the Let-7 primary transcript.  Alignment of the stem-
loop precursors for the Let-7 family revealed highly conserved nucleotides within the loop 
region (Figure 3.2A).  These sequence elements do not contribute to mRNA targeting; 
therefore, we reasoned they maintained conservation due to a regulatory role.  We undertook 
several approaches to test whether the loop sequences of Let-7 were essential for regulated 
Drosha processing.  Our first strategy was to build chimeric Let-7g primary transcripts that 
contained loop regions from other, unregulated miRNAs.  We did detect weak processing in 
P19 cells, though it was unclear if these altered stem-loops were interacting properly with 
the processing machinery (data not shown).  As an alternative we employed site-directed 
mutagenesis to alter conserved residues in the loop (see Figure 3.2A for sites).  Importantly, 
these mutations did not affect folding of the stem-loop structure based on computational 
folding algorithms (mFOLD).  Pri-Let-7g transcripts containing the SD1 or SD2 mutations 
were partially released from the Drosha processing block as evidenced by increased pri-
Let-7g cleavage in P19 nuclear extracts (Figure 3.2B).  The SD3 and SD4 mutations had no 
effect (data not shown).  Mutation at both SD1 and SD2 sites further released the processing 
block.  Importantly, these mutations did not impair general Drosha cleavage as processing 
was unaffected in Hela extracts.
 While this data suggests the requirement for these loop nucleotides, it does not 
formally prove that the Drosha Inhibitor interacts with the loop.  To establish this we 
designed competitor RNAs based on Let-7 stem loop sequences.  If the Drosha Inhibitor 
was binding to the loop region, we reasoned that these competitor RNAs should divert the 
Inhibitor away from the Let-7 primary transcript, restoring processing in P19 cells.  We 
tested competitors corresponding to all 11 Let-7 family members (not including miR-98).  
Competitors that matched Let-7 stem loop sequences restored Drosha processing of Let-7g 
without affecting production of miR-17 (data not shown).  The most effective competitor 
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Figure 3.1.  Embryonic cells contain a Drosha Inhibitor that specifically regulates Let-7.  Radiolabeled 
pri-miRNA substrates corresponding to Let-7g and miR-17 were incubated in P19 or Hela nuclear extracts, as indi-
cated.  Drosha protein, or mock, was immunoprecipitated from P19 nuclear extracts with a polyclonal antibody.  
Immobilized protein was incubated with Let-7g and miR-17 pri-miRNA substrates, as indicated.  Drosha endonu-
clease products were resolved on a denaturing polyacrylamide gel.  The production of Let-7g and miR-17 precursors 
is indicated by arrows.  A labeled RNA oligonucleotide ladder is shown for size reference.    
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was based on Let-7d.  Figure 3.2C illustrates restoration of Let-7g processing in P19 
nuclear extracts in the presence of Let-7d stem loop competitor.  Competitors based on an 
unregulated miRNA, miR-17, had no effect on Let-7 processing (Figure 3.2C).  Interestingly, 
an oligonucleotide corresponding to the loop alone was highly effective, suggesting that a 
stem loop structure is not essential for interaction with regulatory proteins (Figure 3.2C).
The Drosha Inhibitor:
 We next investigated the nature of the Drosha Inhibitor.  We designed an affinity 
purification strategy using the Let-7d loop as a capture reagent.  We confirmed that a linear 
sequence, comprised of loop sequence only, fully 2’-O-methyl modified (for stability), 
and linked to a biotin moiety, was able to restore Drosha processing of Let-7g  when used 
as a competitor (Figure 3.2C).  We bound this capture probe to streptavidin-agarose and 
isolated binding proteins from P19 nuclear extracts.  Proteins were identified by peptide 
mass fingerprinting.  A large number of proteins specifically bound to the Let-7 loop probe, 
as shown in Figure 3.3A.  Many of the proteins belong to the hnRNP family.  This family 
of RNA binding proteins has diverse roles in RNA splicing and has been implicated in the 
regulation of miR-18a processing (Guil & Caceres, 2007).  Interestingly, we also captured 
the RNA binding proteins Lin-28 and Lin-28B.  This protein family was originally identified 
in C. elegans as a genetic mutant that exhibited abnormal cell lineage (Ambros & Horvitz, 
1984).   Family members are characterized as having a cold shock domain and two zinc-
finger domains; a unique domain organization among all known RNA binding proteins 
(Moss, Lee, & Ambros, 1997a).  The biochemical activity of lin-28 is not well characterized, 
though it has been suggested to regulate translation of specific mRNAs (Polesskaya et al., 
2007).
 We confirmed the interaction between Lin-28 and the Let-7 loop by UV-crosslink 
analysis.  Radiolabeled Let-7 stem loop RNA specifically crosslinked a protein in P19 
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Figure 3.2.  The loop region of Let-7 interacts with the Drosha Inhibitor.  (A)  The sequence alignment of Let-7 family members is shown.  Blue 
text indicates the mature miRNA sequence.  Green text indicates the complementary stem strand (not exactly the star strand).  Gray boxes indicate 
regions of homology.  Arrows indicate nucleotides that were mutagenized.  Sequence changes are indicated below the alignment.  (B)  Wild type or 
mutant pri-Let-7g substrates were combined with the pri-miR-17 substrate and incubated in a P19 or Hela nuclear extract.  Drosha products were 
resolved and are indicated.  (C) Pri-miRNA substrates for Let-7g and miR-17 were combined and incubated in P19 nuclear extracts.  Competitor 
RNA transcripts corresponding to the loop plus 12 nucleotides of each stem, or competitor 2’-O methyl oligonucleotides, were included at 10, 50, 
and 250 nM final concentration.  In one case the oligonucleotide had a 3’ Biotin moiety.  The left lane had no competitor.  Drosha products were 
resolved on a denaturing polyacrylamide gel.  Precursor products are indicated by arrows.
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mutant pri-Let-7g substrates wer  combined with the pri-miR-17 substrate and incubated in a P19 or Hela 
nuclear extract. Drosha products were resolved and are indicated. (C) Pri-miRNA substrates for Let-7g and 
miR-17 were combined and incubated in P19 nuclear extracts. Competitor RNA transcripts corresponding to the 
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and 250 nM final concentration. In one case the oligonucleotide had a 3’ Biotin moiety. The left lane had no 
competitor. Drosha products wereresolved on a denaturing polyacrylamide gel. Precursor products are indicated 
by arrows.
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nuclear extracts that matched the size of Lin-28 (Figure 3.3B).  We confirmed the identity 
of the protein by immunoprecipitation of crosslink reactions with an antibody to Lin-28.  As 
evident in Figure 3.3B, one labeled protein of the correct size was recovered from Let-7 
crosslink reactions, but no detectable protein was immunoprecipitated from the control 
reaction.  Importantly, the Let-7/Lin-28 interaction was sensitive to the presence of excess 
competitor Let-7 stem loop RNA.  Control competitors did not disrupt the Lin-28/Let-7 
interaction.
 While this data demonstrated interaction of Lin-28 with the Let-7 stem-loop, it did 
not demonstrate a regulatory role.  To test this we introduced Lin-28 and Lin-28B into NIH-
3T3 cells by retroviral transduction and measured steady state levels of mature miRNAs.  
Microarray analysis indicated that most miRNAs were unchanged, except for a cluster of 
miRNAs reduced in cells expressing either Lin-28 or Lin-28B (Figure 3.4A).  As predicted, 
this cluster included most Let-7 family members.  We confirmed miRNA expression 
changes by RT-PCR (Figure 3.4B).  This method is more sensitive and provides greater 
discrimination among the highly related Let-7 family members.  Let-7f, Let-7g, and Let-7i 
were repressed 240, 90, and 195 fold, respectively, with other family members repressed 
to a lesser degree.  We measured steady state levels of unrelated miRNAs and found no 
significant change.  Importantly, the reduction in Let-7g was at a post-transcriptional step, 
as the level of the primary transcript was not decreased to the same magnitude (2.8 fold).  
Northern blot analysis indicated no accumulation of Let-7g precursor, consistent with a 
block at the Drosha processing step (Figure 3.4C).  While it is formally possible that Lin-28 
promotes a block at the Dicer processing step, this would require an increase in precursor 
turnover at the same rate as precursor production, since no alteration in precursor steady state 
levels is detected. 
 To further confirm a role for Lin-28 in the repression of Let-7 expression, we 
performed RNAi knockdown of Lin-28 in P19 embryonic cells.  Two siRNAs that reduced 
protein levels >90% released the processing block and led to increased mature Let-7 (Figure 
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Figure 3.3.  The RNA binding protein Lin-28 specifically binds to the Let-7 loop region.  (A) Oligonucleotide 
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3.4D, Supplemental Figure 3).  As above, Let-7 family members had differential response to 
siRNA knockdown, with Let-7g, Let-7i, Let-7a, and Let-7f the most affected.  
 Our final goal was to demonstrate the direct regulation of Let-7 processing by Lin-28.  
We generated recombinant Lin-28 and an unrelated RNA binding protein NF-45 in E. coli 
and introduced these purified proteins into our cell free Drosha assay (see Supplemental 
Figure 2 for recombinant proteins).  As described above, Hela extracts will process Let-7g 
with similar efficiency as miR-17.  As shown in Figure 5A, Lin-28 inhibited processing of 
Let-7g without affecting processing of miR-17.  This was not a non-specific affect of RNA 
binding as the control protein (NF-45) had no effect of processing of either substrate.  To 
further support our conclusions, we removed endogenous Lin-28 from the P19 embryonic 
cell extract by immunodepletion.  This enabled processing of Let-7 (Figure 3.5B).  
Discussion:
 Our results outline a regulatory mechanism for the production of the Let-7 family 
of miRNAs.  The primary transcripts for these miRNAs are uniformly expressed during 
embryonic development.  The interaction of a Drosha Inhibitor with the loop structure of the 
pri-miRNAs leads to a block at the Drosha processing step.  We have identified conserved 
nucleotides within the loop that are essential for the Drosha processing block.  This is the 
first report of cis-regulatory elements within the Let-7 primary transcript.  While our work 
focused on the loop region of Let-7, it is interesting that sequence conservation extends 
outside the stem-loop precursor.  Figure 3.6 illustrates that extensive vertebrate conservation 
is present in sequences flanking the precursor.  This sequence may be important for splicing 
of the host gene Wdr82.  However, the proximity to the stem-loop suggests these elements 
play a regulatory role in some aspect of miRNA function.  In further support of this, Let-7 
family members that are not intronic (for example Let-7i, as shown in Figure 3.6) have 
conserved sequence elements flanking the stem-loop.
 We identify Lin-28 as a protein that interacts with the loop region of Let-7.  This 
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Figure 3.4. Lin-28 expression blocks production of Let-7. (A) NIH-3T3 cells were transduced with MSCV 
retroviral constructs that drive expression of Lin-28 or Lin-28B or control, as indicated. Steady state miRNA 
expression levels w re quantit ted using a custom m croarr y p atform 10 days post-infection. N rmalized 
measurements were hierarchically clustered and are plotted as a heat map. Yellow indicates high expression and 
blue low, relative to the mean. Let-7 family members are indicated in red font. (B) Steady state miRNA expres-
sion levels from NIH-3T3 cells expressing Lin-28, Lin-28B, or control were quantitated by real time RT-PCR. 
U6 snRNA was used as the ref rence. Expression of pri-Let-7g was also quantitated by real time RT-PCR. 
β2-microglobulin was used as the reference. (C) Let-7g precursor and mature species in NIH-3T3 cells express-
ing Lin-28, Lin-28B, or control were analyzed by northern blotting. (D) P19 cells were transfected with siRNAs 
targeting Lin-28. Two effective siRNAs were used alone or in combination. 5 days post-transfection mature-
miRNA levels were measured by real time RT-PCR. U6 was used as a reference. Expression of pri-Let-7g was 
also quantitated by real time RT-PCR. β2-microglobulin was used as the reference.
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interaction is specific for Let-7 family members has a dissociation constant in the high 
nanomolar range, based on competitor assays (Figure 3.3B) and fluorescent anisotropy 
binding assays (not shown).   The interaction of Lin-28 with Let-7 inhibits Drosha 
processing.  This RNA binding protein is highly expressed in early development and has 
been proposed as a marker for ES cells (Richards et al., 2004; D. H. Yang & Moss, 2003).  
Differentiation of P19 cells with retinoic acid leads to robust induction of Let-7; Lin-28 
protein decays at the time point that Let-7 processing is enabled (Y. S. Lee et al., 2005; 
Wu & Belasco, 2005).  We propose that a similar decay of this protein during embryonic 
development is what allows Drosha processing of Let-7 and eventual production of the 
mature species. 
 While it is clear that Let-7 processing is negatively regulated by Lin-28, is this 
the primary mode of regulation for the production of this miRNA family?  We have 
previously reported that Let-7 processing efficiency increases >1000 fold during mammalian 
development (Thomson et al., 2004).  Our overexpression studies, however, perturb Let-7 
levels ~100 fold.  It is probable that we are not achieving high enough expression levels to 
fully recapitulate embryonic cells, and western blot analysis confirms this (Supplemental 
Figure 4).  Similarly, our siRNA knockdown studies do not fully eliminate Lin-28 expression 
and it is possible that remaining Lin-28 protein has some repressive function (Supplemental 
Figure 3).  These points suggest we have identified the major regulatory point in Let-7 
production, though we cannot rule out contributions at Dicer processing or at pri-Let-7 
transcription, both of which have been reported (Chang et al., 2008; Wulczyn et al., 2007).
 
 Recently, an independent study has demonstrated that Lin-28 selectively inhibits 
processing of Let-7 (Viswanathan, Daley, & Gregory, 2008).  Similarly, this work suggested 
inhibition at the Drosha processing step, lending further support to our model proposed 
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herein.
 The exact mechanism whereby Lin-28 inhibits Drosha processing is not known.  
Its high affinity binding to Let-7 may simply block access of Drosha or DGCR8 to the 
pri-miRNA.  This binding event may promote turnover of the pri-miRNA, as there is 
no accumulation of this RNA species under conditions where processing is inhibited.  
Alternatively, pri-miRNAs may have a short half life under all conditions and therefore are 
degraded if not rapidly processed by the Drosha machinery.  A final possibility is that the 
Lin-28/Let-7 complex is exported out of the nucleus and shuttled to P-bodies for degradation. 
Lin-28 is known to shuttle between the nucleus and cytoplasm, and has been localized to 
P-bodies, lending support to this hypothesis (Balzer & Moss, 2007b).
 The regulation and developmental expression of the mammalian Lin-28 closely 
parallels that of the C. elegans ortholog, suggesting it performs a similar function in that 
organism.  Expression of let-7 during C. elegans larval development is known to be regulated 
at transcription (Johnson, Lin, & Slack, 2003b).  In lin-28 mutants, however, the production 
of mature let-7 is accelerated by one larval stage.  Similarly, in lin-4 mutants, which have 
elevated expression of lin-28, the production of mature let-7 is delayed (Johnson, Lin, & 
Slack, 2003a).  While it is not known if these effects are a result of direct interaction between 
the lin-28 protein and the let-7 primary transcript, it is possible that the mechanism we report 
here is conserved from C. elegans to mammals.
 The role of Lin-28 in mammalian development is not known.  However, a 
combination of Lin-28, Nanog, Oct-3/4, and Sox2 are sufficient to reprogram human somatic 
cells to pluripotent stem cells (Yu et al., 2007).  The role of Nanog, Oct-3/4, and Sox2 in 
maintaining pluripotency is well established (Pan & Thomson, 2007).     
The additional requirement for Lin-28 in these studies suggests that restoration of the Let-7 
processing block is an essential step for reprogramming stem cells.  These findings strongly 
implicate miRNA expression patterns as important determinants of stem cell fate.
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Materials and methods:
Pri-microRNA substrates: 
 Substrate constructs (stem-loop with ~10nts of ssRNA flanking region) were created 
by the polymerase chain reaction (PCR) using oligonucleotides as the DNA templates:
pri-Let-7g:  a5’-TGCCTGATTCCAGGCTGAGGTAGTCGTTTGTACAGTTTGAGGGTCT
ATGATACCACCCGGTACAGGAGATAACTGTACAGGCAACTGCCTTGCCAGGAACA
GCGCG-3’
pri-miR-17: -;v5’-GTCAGAATAATGTCAAAGTGCTTACAGTGCAGGTAGTGATATGTG
CATCTACTGCAGTGAAGGCACTTGTAGCATTATGGTGAC-3’
Forward and reverse primers added ssRNA flanks as well as 5’ Bgl-II and 3’ Xho-I restriction 
sites. 
Primers for pri-Let-7g: 
Forward  5’-GTCAAGATCTCGTTTCCTTTTGCCTGATTCCAGGCTGA-3’ 
Reverse 5’-GTCACTCGAGGGCAGCTGGCGCGCTGTTCCTGGC-3’ 
Primers for pri-miR-17:  
Forward - 5’-GTCAAGATCTATTGTGACCAGTCAGAATAATGTCAAAGTGCTTACAG 
-3’ 
Reverse 5’-GTCACTCGAGCGAGGCAGCTGTCACCATAATGCTACAAGTGCCT-3’ 
 Resulting PCR products were digested and cloned into a MSCV-splice-donor/splice-
acceptor vector (SDSA3.0; J.M. Thomson and S.M. Hammond, unpublished results) based 
on the MSCV-puro vector (Clontech).   
 Pri-microRNA transcription templates were created from the pri-microRNA 
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constructs described above; PCR was employed to add on a 5’ T7 promoter 
(5’-TCGTAATACGACTCACTATAGGGTCCGCTAGCCTAGCTACTACCA-3’ and 5’- 
ATAAGTATGATATTGTCAAGGAAACCC-3’).  Radiolabeled pri-microRNAs were created 
using T7 RNA polymerase (NEB) in accordance with the manufacturer’s instructions.  The 
resulting pri-microRNA substrates were (pri-microRNA sequences are in bold type; flanking 
vector sequences are italicized):
Pri-Let-7g:
TCCGCTAGCCTAGCTACTACCAGGTGAGTGGAGATCTCGTTTCCTTTTGCCTGAT-
TCCAGGCTGAGGTAGTCGTTTGTACAGTTTGAGGGTCTATGATACCACCCGGTA-
CAGGAGATAACTGTACAGGCAACTGCCTTGCCAGGAACAGCGCGCCAGCTGC-
CCTCGAGGTTTAAACGAATTCAGGGTTTCCTTGACAATATCATACTTAT
Pri-miR-17:
TCCGCTAGCCTAGCTACTACCAGGTGAGTGGAGATCTATTGTGACCAGTCA-
GAATAATGTCAAAGTGCTTACAGTGCAGGTAGTGATATGTGCATCTACTGCAGT-
GAAGGCACTTGTAGCATTATGGTGACAGCTGCCTCGCTCGAGGTTTAAACGAAT-
TCAGGGTTTCCTTGACAATATCATACTTAT.
Cell culture and nuclear extract preparation:
 P19 cells were differentiated for 10 days in retinoic acid, as described(Thomson et 
al., 2006).  Undifferentiated and differentiated P19 cells, and Hela S3 nuclear extracts were 
prepared as previously described(Dignam, 1990).  In brief, cell pellets, washed once in phos-
phate buffered saline (PBS), were resuspended in 2.5 volumes of Buffer A [10mM HEPES, 
pH 7.9, 10mM KCl, 1.5mM MgCl2, 0.2mM EDTA, 1mM dithiotreitol (DTT), 1mM phe-
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nylmethylsulfonyl fluoride (PMSF), 20% glycerol and Complete protease inhibitors (CPI, 
Roche)] and incubated on ice for 10 minutes. Cells were then lysed using 5-10 passes in a 
dounce homogenizer.  Nuclei were centrifuged at 1200rpm for 5 minutes, followed by cen-
trifugation 15,000 x g for 15 minutes and the resulting supernatant was discarded.  Pelleted 
nuclei were extracted in buffer C [20mM HEPES, pH 7.9, 420mM NaCl, 1.5mM MgCl2, 
0.2mM EDTA, 1mM DTT, 1mM PMSF, 20% glycerol and CPI] at 4oC for 30 minutes (3ml 
of buffer C was used per 1x109 cells).  Nuclear debris was then pelleted by centrifugation at 
15,000rpm for 30 minutes and the resulting nuclear extract was dialyzed for 5 hours against 
>50 volumes of buffer D [20mM HEPES, pH 7.9, 100mM KCl, 1.5mM MgCl2, 0.2mM 
EDTA, 1mM DTT, 1mM PMSF and 20% glycerol).  
Cell free Drosha processing assay:
 Drosha assay reactions were carried out as previously described with some modi-
fications (Lee et al., 2002).  1x105cpm each of pri-Let-7g and pri-miR-17 transcripts were 
combined and incubated with 100mg of nuclear extract (where indicated, either 100mg P19 
extract, 100mg of differentiated P19 extract, 100mg of Hela extract or 50mg P19 + 50mg 
HeLa extract) + 0.1ml RNasin (Promega) for 30 minutes at 37oC.  RNA was isolated using 
Trizol and precipitated in cold isopropanol.  RNA pellets were washed once in 70% ethanol 
and resuspended in 15ml of formamide loading buffer.  Processed pri-microRNA products 
were resolved on a 12.5% acrylamide-8M urea sequencing gel and visualized by autoradiog-
raphy using a Storm phosphoimager (GE Life Sciences); pre-microRNA band intensities 
were quantitated using Imagequant software (GE Life Sciences).  A molecular weight ladder 
of radiolabeled, concatamerized RNA oligos was used to determine the size of the pre-mi-
croRNA products.
Drosha immunoprecipitation:
 For Drosha assays using immunoprecipitated Drosha, we first generated rabbit poly-
clonal anti-Drosha antibody using the peptide sequence CPEEAEDIKK.   250μl of P19 
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nuclear extract was precleared with 25μl protein-A sepharose and incubated either with 40μl 
of affinity-purified Drosha antibody and 45μl of packed protein-A sepharose or with protein-
A sepharose alone. Igepal CA-630 (Sigma) was added to 0.5% v/v and immunoprecipitation 
reactions were incubated for 1 hour at 4oC. Beads were then washed three times in buffer D 
+ 0.5% Igepal. Individual Drosha reactions were carried out as described above using 10μl of 
immobilized protein from each immunoprecipitation reaction, pri-miRNA substrates indi-
vidually or combined, and buffer D and 1μl RNasin.  
Drosha assay northern blot:
 To identify pre-microRNA products, Drosha assays were carried out as described 
above except that 0.15mg of unlabeled pri-microRNA was individually incubated in Hela 
extract.  Separated RNA products were then transferred onto Nylon (Amersham) which 
was then UV cross-linked and hybridized to locked nucleic acid (LNA) probes (Integrated 
DNA Technologies) that were labeled on the 5’ end with T4 polynucleotide kinase (NEB). 
Hybridizations occurred overnight at 65oC, were washed three times at 65oC in 0.4xSSC + 
0.2%SDS and cross-reacted bands were visualized by autoradiography. 
Northern probe sequences (lower case denotes LNA; upper case denotes DNA):
Let-7g: 5’- ACTgTaCaAaCgAcTaCcTcA -3’
miR-17-3p: 5’-ACAaGtGcCtTcAcTgCaGt -3’
Stem-loop RNA competitor assay:
 Drosha reactions were pre-incubated on ice for 30 minutes with unlabeled microRNA 
stemloop RNAs added to final concentrations of 12.5nM, 125nM and 1250nM, respectively.  
The competitor RNAs were either 2’-O-methlyated RNA oligos (Dharmacon), or were in 
vitro transcribed from long double stranded DNAs (dsDNAs) encoding a T7 promoter, the 
upper 10 basepairs of stem and the loop of the indicated pri-microRNA.  The dsDNAs were 
created by annealing a T7 adapter primer to a longer microRNA primer, followed by a brief 
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PCR extension step with Pfu DNA polymerase (Promega) (95oC, 5 minutes, 59oC, 1 minute, 
72oC, 10 minutes for 1 cycle).
T7 adapter: 
5’- gatgTAATACGACTCACTATAGGG-3’
>hsa-let-7d
5’-caggtcgtatagttacctccttgtgggcaaaatccctgccctaaaactatgcaaccccctatagtgagtcgtattaCATC -3’ 
>hsa-let-7a-2 
5’-gaggctgtacagttatctcccttgatgtaattctaaactatacaaccccctatagtgagtcgtattaCATC -3’
>hsa-let-7f-1 
5’-agattgtatagttatctcctgaacagggtaaaatcactaccccacaactatacaatcccctatagtgagtcgtattaCATC -3’
>hsa-let-7c 
5’-aaggttgtacagttaactcccagggtgtaactctaaaccatacaaccccctatagtgagtcgtattaCATC -3’
>hsa-let-7a-3 
5’-tagattgtatagttatcccatagcagggcagagccccaaactatacaaccccctatagtgagtcgtattaCATC -3’
>hsa-let-7i 
5’-agcttgcgcagttatctccacagcgggcaatgtcacaacccgaccaacagcacaaacccctatagtgagtcgtattaCATC 
-3’
>hsa-let-7f-2 
5’tagactgtatagttatctccaagatggggtatgaccctaaaactatacaatcccctatagtgagtcgtattaCATC -3’
>hsa-let-7g 
5’ggcctgtacagttatctcctgtaccgggtggtatcatagaccctcaaactgtacaaacccctatagtgagtcgtattaCATC -3’
>hsa-let-7a-1 
5’tagattgtatagttatctcccagtggtgggtgtgaccctaaaactatacaaccccctatagtgagtcgtattaCATC -3’
>hsa-let-7e 
5’gaggccgtatagtgatctccttgggtgtcctcctcaactatacaaccccctatagtgagtcgtattaCATC -3’
>hsa-let-7b 
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5’aggttgtatagttatcttccgaggggcaacatcactgccctgaaaccacacaaccccctatagtgagtcgtattaCATC -3’
>hsa-mir-17 
5’tcactgcagtagatgcacatatcactacctgcactgtccctatagtgagtcgtattaCATC -3’
>hsa-mir-20a 
5’ctcataatgcagtagataactaaacactacctgcactatccctatagtgagtcgtattaCATC -3’
Lin28 immunodepletion Drosha assay:
 Protein A-sepharose beads were washed 3 times in “Hi DTT” immunoprecipitation 
(IP) buffer [20mM HEPES, pH 7.6, 2mM MgCl2, 150mM NaCl, 10mM DTT, 1mM PMSF, 
0.5% NP-40] followed by 5 washes in IP buffer [20mM HEPES, pH 7.6, 2mM MgCl2, 
150mM NaCl, 1mM DTT, 1mM PMSF, 0.5% NP-40].  15mL of anti-Lin-28 antibody (Ab-
cam) was prebound to 30mL protein A sepharose beads (Sigma) for 1 hour at 25oC in IP 
buffer, followed by extensive washing with buffer D + 0.5% NP-40.  100mL of P19 nucelar 
lysate (5mg/ml) was diluted 2-fold in buffer D + 2ml of RNasin and rotated overnight at 4oC 
with either the antibody-beads mixture or beads alone as a mock.  
Recombinant protein competitor assay:
 Drosha assays were carried out as described above except that, where indicated, 2ng, 
20ng and 200ng of recombinant protein was added to Hela extract/pri-microRNA mixtures 
before the 37oC incubation step.
RNA affinity pulldown:
 30ml of 100mM Let-7d Loop biotinylated 2’-O-methylated RNA oligonucleotide, 
(5’UUmAmGmGmGmCmAmGmGmGmAmUmUmUmUmGmCmCmCmAmCmAmAmG-
mGmAmGmGmU-18s-Bi 3’, Dharmacon) or a non-specific control oligo (5’Bi-18S-18S-
mAmUmAmAmGmUmAmUmGmAmUmAmUmUmGmUmC-3’, Dharmacon) were bound 
to 150ml of streptdavidin-agarose beads (Fluka) for 1 hour at 37oC in “high salt” buffer D 
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(+1M KCl).  Bead-oligo mixtures were washed 3 times in buffer D+T.  15mg of P19 cell 
nuclear extract (equivalent to 1x109 cells) was diluted up to 20ml in buffer D+T, pre-cleared 
with streptavidin agarose beads and incubated with bead-oligo mixtures at 25oC for 3 hours.  
Beads were then washed 6 times in Buffer D+T and bound proteins were eluted using SDS 
protein loading buffer + 50mM DTT.  Proteins were separated on a 4-20% pre-cast polyacryl-
amide gel (Jule Biotechnologies) and stained with Coomassie brilliant blue G-250 (Bio-Rad); 
appropriate bands were excised and submitted to the UNC-Duke Michael Hooker Proteomics 
Facility for tryptic digestion and MALDI-TOF footprinting.
UV crosslinking:  
 Cross-linking experiments were carried out essentially as previously described (Myer 
et al., 1997).  In brief, 50mg of P19 nuclear lysate, 3mg of yeast tRNA and  5x105 cpm of 
hsa-Let-7d or hsa-miR-20a loop probes (same competitor RNA sequences as in the “stem-
loop RNA competitor assay” above) were combined and adjusted to a volume of 14ml with 
buffer D [20mM HEPES, pH 7.9, 20% glycerol, 100mM KCl, 1.5mM MgCl2, 0.2mM 
EDTA, 1mM DTT, 1mM PMSF].  Reaction mixtures were incubated for 30 minutes at 25oC, 
followed by irradiation with 1 Joule of UV light. Each sample was then incubated with 10mg 
RNase A for 30 minutes at 37oC.  The samples were then either prepared for immunoprecipi-
tation (see below) or boiled in SDS protein loading buffer for 5 minutes (“input” samples).  
Where indicated, 2’-O-methyl oligonucleotides were added to the final concentration of 
12.5nM, 125nM or 1250nM to the reaction mixture and pre-incubated at 25oC for 30 minutes 
prior to the addition of the labeled probe.
2’-O-methyl competitor sequences:
Let-7d loop 2’-O-methyl: 5’mUmUmAmGmGmGmCmAmGmGmGmAmUmUmUmUmG-
mCmCmCmAmCmAmAmGmGmAmGmGmU3’
Non-specific 2’-O-methyl:
5’mAmCmCmAmAmCmAmGmGmCmCmGmGmGmAmCmAmAmGmUmGmCmAmmAU-
mAmAmC3’
Crosslinking Immunoprecipitations:
 RNase A-treated samples were boiled in TSD buffer [50mM Tris-Cl, pH 7.5, 1% SDS, 
5mM DTT] for 10 minutes and diluted 10-fold in TNN buffer [50mM Tris-Cl, pH 7.5, 250mM 
NaCl, 5mM EDTA, 0.5% NP-40 and complete protease inhibitor (Roche)].  Diluted lysates were 
pre-cleared with protein-A sepharose beads (Sigma) followed by immunoprecipitation overnight 
at 4oC with anti-Lin28 antibody (Abcam) and protein A-beads or with protein-A beads alone 
(“mock” immunoprecipitation).  Protein-bound beads were washed extensively with cold TNN 
buffer; proteins were eluted by boiling SDS protein loading buffer and separated on a 12% SDS-
PAGE gel which was subsequently fixed and dried down.  Radiolabeled proteins were visualized 
by autoradiography.  
Recombinant proteins:
 cDNAs were amplified from full-length ESTs coding for NFAT-45 and Lin-28 as well as 
a partial EST for Lin28B (Open Biosystems) using the primers 
Lin-28:
5’- tacgaattcACCATGGACTACAAAGACGATGACGACAAGGGCTCGGTGTCCAACCA-3’ 
5’-catgcggccgcTCAATTCTGGGCTTCTGGG-3’
Lin28B:
5’- AGCCAGAAAAACTGCCCGGGCTGGCAGAGGACGAACCCCAGGTTCTGCATG-
GC-3’, 
5’- TGACGACAAGGCCGAAGGCGGGGCAAGCAAAGGTGAAGAGCCAGAAAAACT-
GCCCG-3’
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5’-tacgaattcACCATGGACTACAAAGACGATGACGACAAGGCCGAAG-3’ and 5’- catgcggc-
cgcCTAAGTCTTTTTCCGTTTCTGAATCA -3’were used to rebuild the 5’ end of the Lin28B 
gene by overlap extension PCR.  
NFAT 45:
5’- tacgaattcACCATGGACTACAAAGACGATGACGACAAGAGGGGTGACAGAGGAC-3’ 
5’- catgcggccgcTCACTCCTGAGTCTCCATGC-3’ 
 Flag-tagged cDNAs were cloned into pcDNA 3.0 using 5’ EcoRI and 3’ NotI restriction 
sites.  cDNAs were subsequently subcloned into pMSCV-puro-IRES-GFP(He et al., 2005).  For 
over-expression studies, NIH-3T3 cells were transduced using virus generated with the LinXE 
ecotropic packaging line.   Cells were selected with puromycin.  10 days post-infection total 
RNA and protein samples were isolated using Trizol and SDS loading buffer, respectively.  mi-
croRNA expression levels were examined by quantitative real-time PCR (qRT-PCR) as well as 
by microRNA microarray as previously reported(Thomson et al., 2004; Thomson et al., 2006).  
Protein over-expression was verified by western blot with a Lin-28 antibody (Abcam).  
Purification of His-tagged Lin-28 and NF-45:
 The following primers were used to amplify mouse coding sequences for NF-45 and 
Lin-28; 6xHis-NF45 5’-ggccatcatcatcatcatcacaggggtgacagagga-3’; BsmFI_6xHis_NF45_push  
5’- cagtgggacgctgtctcaccatgggccatcatcatc-3’; XhoI_NF45 5’- catgctcgagtcactcctgagtctccatgc-3’; 
6x_His_Lin28 5’-ggccatcatcatcatcatcacggctcggtgtccaac-3’; NcoI_6xHis_Lin28_push 5’- atac-
catgggccatcatcatcatcac-3’; Lin28_XhoI 5’- catctcgagtcaattctgggcttctggg-3’. PCR products were 
inserted into the pET28b vector (Novagen) after NcoI/XhoI (vector; Lin28) or BsmFI/XhoI 
(NF45) digestion. BL21 (DE3) pRIL E. coli (Stratagene) served as the host for protein expres-
sion. Briefly, positive clones were grown in 1 liter of LB to a density of 0.6 OD600 at which 
time recombinant protein was induced by the addition of 0.25mM IPTG and allowed to grow 
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for an additional 3 hours. Cells were harvested by centrifugation and cell pellets suspended in 
30 ml Talon resin equilibration/wash buffer 50mM sodium phosphate, pH 7.0; 300mM NaCl 
(Clontech). Cells were lysed by sonication and cleared by centrifugation. The cell lysate was 
incubated with 5 ml of equilibrated Talon resin beads and allowed to bind at 40C for 1 hour. The 
resin was batch washed 3 x 20 minutes in 30 ml of equilibration/wash buffer and applied to a 
disposable column. The protein was eluted along a 50 ml gradient of equilibration buffer con-
taining 0-200mM imidazole and fractions collected. Pure fractions were combined and dialysed 
in buffer D; 20mM Hepes, pH 7.9; 100mM KCl; 0.2mM EDTA; 1.5mM MgCl2; 1mM PMSF; 
1mM DTT; and 20% Glycerol. Aliquots were stored at -800C.  
Purification of Flag-tagged recombinant Lin-28:
 Twenty 10cm plates of HEK293 cells were transiently transfected with either Flag-
tagged NFAT-45, Lin28 or Lin28B over-expression constructs using Fugene 6 (Roche) accord-
ing to the manufacturer’s instructions.  After 48 hours, cells were harvested by scraping in cold 
PBS, centrifuged at 1200rpm for 5 minutes and lysed in IP buffer.  Lysates were pre-cleared 
with 50ml of protein A beads for 1 hour followed by immunoprecipitation with 50ml of M2 flag 
agarose beads (Sigma) overnight at 4oC.  Beads were then pelleted and washed 10 times in cold 
buffer D followed by elution with Flag peptide (Sigma) at 400 mg/ml in buffer D.  Purity of 
eluted proteins was verified by SDS-PAGE followed by coomassie blue staining of the gel.
Lin-28 knockdown/overexpression studies:
 P19 cells were seeded in six-well plates at ~40% confluency and 2 hours later were 
transfected with siRNAs to either GAPDH or Lin-28 (Dharmacon) using Lipofectamine 2000 
(Invitrogen) as instructed by the manufacturer.  Total RNA and protein was isolated approxi-
mately 72 hours later using Trizol and SDS loading buffer, respectively. microRNA expression 
levels were examined by quantitative real-time PCR (qRT-PCR)(Thomson et al., 2006).  
siRNA sequences:
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si#2: 5’ ggagacaggugcuacaacuuu3’
si #9: 5’ ugacguaucuugugcguuuuu 3’
          
si#12: 5’ aaaugugucucacggguuuuu 3’
 Lin-28 and Lin-28B was ectopically expressed using MSCV retroviral expression con-
structs.  MSCV retrovirus was transduced into NIH-3T3 cells and cells were selected with 
puromycin.  10 days post-infection cells were harvested and miRNA expression levels were 
characterized by microarray analysis and real time RT-PCR essentially as described (Thomson 
et al., 2004; Thomson et al., 2006).  Northern blot analysis was performed as described, using a 
radiolabeled LNA probe for Let-7g (Thomson et al., 2006).
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Chapter 4: 
An unprecedented view of pre-microRNA uridylation and degradation in murine 
embryonic carcinoma cells.
Summary:
 MicroRNAs (miRNAs) play crucial roles in orchestrating gene-expression patterns 
during development as well as in the onset of many diseases.  However, before these 
small non-coding RNAs can bind to cognate sequences in target mRNAs, they must first 
be processed from larger RNA precursors in a well-characterized biogenesis pathway.  
Surprisingly, in early development, as well as in poorly differentiated tumors, many mature 
miRNAs are largely absent due to a post-transcriptional block in their biogenesis.  Recently, 
it was shown that Lin28, an embryonic cell-specific RNA binding protein, blocks the 
processing of the let-7 family of tumor suppressor miRNAs.  While the biochemical nature 
of the Lin28 block isn’t entirely clear, recent intriguing evidence suggests that Lin28 recruits 
the terminal uridyl transferase, TUT4 to let-7 precursor miRNAs (pre-miRNAs) leading to 
oligo-uridylation and, presumably, degradation of the pre-miRNA.  This observation raises 
the possibility that the global repression of mature miRNAs occurs, in part, at the level of 
pre-miRNA uridylation.  However, current technical limitations in pre-miRNA detection 
have made this hypothesis difficult, if not impossible to address.  Here, we describe the 
development of a method termed “RM-seq” (for Reverse-transcription and Multiplexed PCR 
in conjunction with deep sequencing) to assess the abundance, uridylation and degradation 
of over 40 pre-miRNAs simultaneously in P19 embryonic carcinoma (EC) cells.  Using this 
technique, we demonstrate that many pre-miRNAs, in addition to those of the let-7 family, 
are 3’ oligo-uridylated, possibly by a mechanism independent of the Lin28/TUT4 pathway.  
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Furthermore, we show that the degradation of uridylated pre-miRNAs is governed, in part, by 
the 3’-5’ exosome pathway.  
Introduction: 
 microRNAs (miRNAs) are small non-coding RNAs with important functions in 
embryonic development as well as in the pathogenesis of various diseases including cancer 
(Bushati & Cohen, 2007).  It is now clear that the precise control of miRNA abundance relies 
not only on the transcription of miRNA genes but also depends on the post-transcriptional 
regulation (Newman & Hammond, 2010).  Many steps in the miRNA biogenesis pathway 
after transcription are regulated but, to date, the most intensely studied phenomena of 
regulated miRNA processing center on the RNaseIII enzymes Drosha and Dicer and the 
modulation of their accessibility and activity towards particular miRNA precursors.  In 
one instance, effector proteins of signal transduction pathways either increase or decrease 
Drosha processing of target pri-miRNAs, either by binding directly to pri-miRNA sequences 
(Davis et al., 2010) or by modulating the interaction of Drosha with RNA-helicases, p68 
and/or p72 (Suzuki et al., 2009; Yamagata et al., 2009).  Another phenomenon is the binding 
of regulatory proteins to conserved sequences in the loop region of pri- and pre-miRNAs, 
leading either to activation or repression of Drosha and Dicer processing.  The best-studied 
example of this second kind of regulation is the early embryonic processing block of let-7 
miRNA precursors by the embryonic-stem (ES) cell-specific RNA binding protein Lin28.  
Lin28 recognizes the conserved GGAG motif  in the 3’ region of the loop (Heo et al., 2009).  
While Lin28 was originally shown to block Drosha processing of pri-let-7 in vitro (Newman, 
Thomson, & Hammond, 2008; Viswanathan et al., 2008), subsequent studies have suggested 
that Lin28 also blocks pre-let-7 processing by Dicer, and, even more intriguingly, facilitates 
the turnover of pre-let-7 (Heo et al., 2008; Rybak et al., 2008).  Lin28-mediated turnover of 
pre-let-7 is thought to occur by the recruitment of the terminal uridyl transferase TUT4 to 
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the pre-let-7-Lin28 complex in the cytosol.  TUT4 adds an oligo-uridine (oligo-U) “tail” to 
the 3’ end of pre-let-7, which is thought to block Dicer processing while presumably leading 
to degradation of the pre-miRNA (Heo et al., 2009).  The exonuclease that might carry out 
decay of uridylated pre-let-7 is unknown.  
 The observation of pre-let-7 uridylation by Lin28/TUT4 is an exciting finding 
which bolsters the relatively new idea that certain TUTases add an oligo-U tail to the 3’ 
end of RNAs, ultimately leading to turnover (Mullen & Marzluff, 2008; Wilusz & Wilusz, 
2008).  However, many non-let-7 miRNAs are also post-transcriptionally repressed during 
embryonic development and in poorly differentiated tumors (J. Lu et al., 2005b; Thomson et 
al., 2006); furthermore, recent evidence suggests that Lin28/TUT4 might also regulate other 
pre-miRNAs in addition to pre-let-7.  Thus, it will be crucial to determine whether non-let-7 
pre-miRNAs are uridylated and/or degraded.  Answering this question is very challenging 
due to the technical limitations in our ability to detect pre-miRNAs.  Pre-miRNAs are 
generally far less abundant than mature miRNAs, making detection by northern blot very 
difficult.  Other, well-established, techniques such as primer extension, RNase protection 
assays (RPA;(Cai & Cullen, 2007)) and intramolecular circularization followed by RT-PCR 
(cRT-PCR; (Basyuk et al., 2003)) are more sensitive but are laborious and cannot be used to 
simultaneously monitor many pre-miRNAs.  
 The emergence of deep sequencing technology has provided researchers in the 
miRNA field with a powerful tool for studying mature miRNA abundance (Hafner et al., 
2008).  Preparation of a cDNA library for deep sequencing entails the ligation of RNA 
“linker” oligonucleotides (oligos) to the 5’ and 3’ ends of total cellular RNA or an enriched 
pool of a certain type of RNA (e.g. poly-adenylated mRNAs or miRNAs); the ligation is 
followed by RT-PCR using the linker sequences (Hafner et al., 2008).  However, this general 
library preparation scheme is not amenable to pre-miRNAs for several reasons.  First, pre-
miRNAs are highly base-paired and contain a 2 nucleotide 3’ overhang; this makes the 5’ end 
of the pre-miRNA largely inaccessible for ligation of the 5’ linker.  Furthermore, RNAs such 
65
as ribosomal RNA (rRNA) and tRNAs are so abundant that they are the predominant RNAs 
to which the linker oligos are ligated; therefore, low abundance RNAs such as pre-miRNAs, 
are rarely, if ever, observed in deep sequencing data.  Here, we report the development of 
a new technique, based on high-throughput sequencing, termed “RM-seq” (for Reverse-
transcription and Multiplexed PCR in conjunction with deep sequencing) which we have 
used to extensively monitor the uridylation and degradation status of over 40 microRNAs 
simultaneously in embryonic carcinoma (EC) cells.  
Results:
RM-seq method:
 The preparation of an RM-seq cDNA libarary is outlined in Figure 4.1.  To eliminate 
most abundant RNAs, we isolated pre-miRNA-sized RNA from total RNA using denaturing 
gel electrophoresis (STEP 1).  There is only one ligation reaction in the RM-seq protocol (as 
opposed to two ligation steps in conventional library preparation); a linker oligo is ligated 
to the 3’ end of the RNA, which corresponds to the 5’ sequencing primer during the deep 
sequencing reaction (STEP 2).  This eliminates the abundant “linker-only” dimer PCR 
product that can greatly reduce the efficiency of cellular RNA sequence counts during the 
deep sequencing run.  Following reverse-transcription with a linker specific primer (STEP 
3), a miRNA-specific multiplex PCR simultaneously enriches 41 pre-microRNAs sequences 
and adds the second linker sequence required for cluster amplification and sequencing-by-
synthesis (STEP 4).  The resulting cDNA is then subjected to deep sequencing (STEP 5).  In 
order to analyze the sequence data, we first separated the reads by barcode, which is the first 
3nts of each read.  The barcodes were then removed, yielding a 33-mer pre-miRNA-specific 
sequence (Figure 4.1A).  The RM-seq cDNA library is relatively complex; because pre-
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Figure 4.1: The RM-seq cDNA library protocol.  A) Schematic for the construction of RM-seq deep sequencing library 
as described in the beginning of the “Results” section.  B) Control for effective amplification of pre-miRNAs out of total 
RNA from P19 embryonic carcinoma (EC) cells.  For size controls the protocol in A) was carried using either a synthetic 
mature let-7a microRNA (lane 1) or synthetic pre-let-7a-2 (lane 2); a majority of the resulting P19 library PCR product is 
within the pre-miRNA size-range, suggesting an enrichment of pre-miRNAs over mature miRNAs.
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miRNAs are amplified from the 5’ end during the PCR reaction, any information regarding 
the 3’ end heterogeneity should be retained.  As different pre-miRNAs in a given cell type are 
likely to vary greatly in abundance, we limited the multiplex PCR step to 10 cycles (followed 
by 19 additional cylces using only the linker sequences).  To ensure that contamination of the 
cDNA library by mature miRNAs was minimal, we prepared parallel RM-seq samples using 
synthetic mature and pre-miRNAs as size standards.  In our RM-seq library prepared from 
P19 EC cell RNA, the predominant PCR product comigrated with the product created using 
the synthetic pre-miRNA, suggesting that the enrichment of pre-miRNAs was successful 
(Figure 4.1B).
Examining pre-miRNA levels during cell differentiation using RM-seq:
 It is possible that inherent short-comings of multiplex-PCR could skew the apparent 
abundance of different pre-miRNAs; factors like the variation in annealing temperatures 
between miRNA-specific primers and different melting temperatures of the pre-miRNA 
cDNA hairpins themselves could cause variation in amplification efficiency of certain 
pre-miRNAs.  To test whether changes of pre-miRNA levels between samples using RM-
seq reflect previously observed changes, we examined a differentiation time course of 
P19 EC cells treated with all-trans retinoic acid (RA).  It is known that ES cell specific 
miRNAs (miR-290 and miR-302 families) are transcriptionally downregulated during ES 
cell differentiation (Marson et al., 2008); consistent with this data, we observed a sharp 
decrease in ES-specific pre-miRNA levels during P19 differentiation.  Less is known about 
the transcriptional control of let-7 genes during embryogenesis; several groups have reported 
conflicting results using northern blotting to detect let-7 pre-miRNAs: in northern blots using 
staged mouse embryo RNA, pre-let-7 sized bands were detected only in later development 
(Schulman et al., 2005; Thomson et al., 2006).  In another instance, pre-let-7-sized bands 
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were observed in both ES cells and differentiated tissue RNA (Rybak et al., 2008; Wulczyn et 
al., 2007).  In neither instance were the identities of the pre-let-7-sized bands verified.  Using 
RM-seq, we observed that 11 out of 12 let-7 pre-miRNAs (as well as miR-125 pre-miRNAs 
[lin-4 homologs], data not shown) were greatly increased in differentiated P19 cells. (Figure 
4.2A).  Northern blotting for a let-7a and miR-302c shows that changes in mature miRNAs 
largely correlate with pre-miRNA levels during P19 cell differentiation (Figure 4.2B). 
Persistent uridylation of let-7 pre-miRNAs in differentiated P19 cells:
 We next investigated our RM-seq data for pre-miRNA 3’ end heterogeneity.  For 
each pre-miRNA, we counted the number of 33nt sequence reads that perfectly aligned 
to the complete pre-miRNA sequence that is annotated in miRBase (http://www.mirbase.
org/) as well as truncated reads and reads with 3’ untemplated nucleotides.  Consistent with 
the possibility of the Lin28/TUT4-mediated uridylation of pre-let-7, we observed an over-
representation of 3’ untemplated uridines on 11 of 12 let-7 pre-miRNAs.  Previously, two 
let-7 pre-miRNAs were shown to be uridylated in vivo (pre-let-7a-1 and pre-let-7d(Heo et al., 
2008)); we found pre-let-7a-1 and pre-let-7d to be 1.8% and 4.3% uridylated, respectively 
(Figure 4.3A).  Unexpectedly, many let-7 family members remained substantially uridylated 
during P19 differentiation (Figure 4.3A).  For pre-let-7a-2, pre-let-7c-1, pre-let-7d and pre-
let-7e, uridylated reads were not greatly enriched over other modified reads (0.9x, 1.2x, 1.5x 
and 0.5x fold more uridylated reads over all other modified reads combined, data not shown), 
suggesting these uridylated reads might be due to sequence error.  However, the remaining 
let-7 pre-mIRNAs had a clear over-representation of uridylated reads (7a-1: 7.1x / 7b: 11.0x 
/ 7c-2: 16.2x / 7f-1: 5.2x / 7f-2: 8.2x / 7g: 6.8x / 7i: 8.1x / miR-98: 5.6x fold more uridylated 
reads than all other modified reads combined, data not shown), raising the possibility that 
many let-7 pre-miRNAs are U-tailed in differentiated cells.  To rule out the possibility that 
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Figure 4.2: Full-length pre-miRNA levels during neuronal differentiation of P19 cells.  A) Read counts 
(y-axis) of pre-miRNA were plotted against time points during P19 differentiation.  Only 33nt sequences align-
ing perfectly to the annotated 3’ end of pre-miRNAs were used.  B) Northern blot for mature miRNA using the 
total RNA from the experiment in (A).
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the untemplated uridines were randomly distributed across the precursor sequence, we 
aligned both perfectly matched (“No Mod”) and uridylated (“Uridylated,” Figure 4.3B) reads 
of pre-let-7a-1 and pre-let-7g to their full-length pre-miRNA sequence.  There was a clear 
concentration of uridylated reads just beyond the 3’ Drosha cut site (Figure 4.3C), indicative 
of TUTase activity.
Diverse pre-miRNAs are uridylated in P19 EC cells:
 Surprisingly, we found that many other pre-microRNAs, including those 
corresponding to the tumor suppressor miR-15a (14.5% +U) and the early embryonic miR-
302C (9.4% +U), were uridylated in P19 cells (Figure 4.4A).  Other pre-miRNAs that were 
notably uridylated were pre-miR-103-1, pre-miR-23a, pre-miR-23b and pre-miR-30e (data 
not shown).  This is consistent with a recent report in which the authors observed widespread 
untemplated uridylation on 3’ mature miRNA strands and proposed the possibility of pre-
miRNA uridylation similar to that mediated by Lin28 (Chiang et al., 2010). Inspection of the 
most abundant reads at each position revealed that these pre-miRNAs possessed bona fide 
oligo-uridine tails (Figure 4.4B and 4.4C); therefore, most untemplated uridines were not 
due to sequencing error.  
Accumulation of uridylated pre-miRNAs upon exosome disruption:
 In eukaryotes, oligo-uridylation has been shown to mediate RNA degradation by 
facilitating the recruitment of exonucleases.  Therefore, we hypothesized that depletion of 
the RNA degradation machinery would cause an accumulation of uridylated pre-microRNAs 
that are normally targeted for turnover.  We used RM-seq to examine pre-miRNAs in P19 
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Figure 4.3: let-7 pre-miRNAs are uridylated in differentiated P19 EC cells.  A) bar graph displaying the percent uridylated pre-miRNA reads 
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matching reads.  Reads are aligned to the annotated pre-miRNA sequence that has been extended by 5 nts into the pri-miRNA sequence.  A read is 
scored as either “No Mod” (perfect match) or “Uridylated” (contains one or more untemplated uridines (grey letters).  It should be noted that the 
scored uridylated reads are not necessarily homogeneous (see the two aligned uridylated reads in the same position); however, a large majority of 
uridylated reads in a given position is one sequence.  C) position of perfect and uridylated reads in 10 days differentiated P19 cells for pre-let-7a-1 
and pre-let-7g.
Figure 4.3: let-7 pre-miRNAs are uridylated in differentiated P19 EC cells. A) bar graph displaying the 
percent uridylated pre-miRNA reads during neuronal differentiation of P19 c lls. B) Sch matic depicting strat-
egy used to graphically map distribution of uridylated versus perfectly matching reads. Reads are aligned to the 
annotated pre-miRNA sequence that has been extended by 5 nts into the pri-miRNA sequence. A read is scored 
as either “No Mod” (perfect match) or “Uridylated” (contains one or mor untemplated u idines (grey letters). It 
should be noted that the scored uridylated reads are not necessarily homogeneous (see the two aligned uridylat-
ed reads in the same position); however, a large majority of uridylated reads in a given position is one sequence. 
C) position of perfect and uridylated reads in 10 days differentiated P19 cells for pre-let-7a-1 and pre-let-7g.
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B) Location of untemplated uridines:
C) Sequence alignment:
AGAGGTAGTAGGTTGCATAGTTTTAGGGCAGAGATTTTGCCCACAAGGAGTTAACTATACGACCTGCTGCCTTTCT
                             AGAGATTTTGCCCACAAGGAGTTAACTATACGA     
                              GAGATTTTGCCCACAAGGAGTTAACTATACGAC     
                               AGATTTTGCCCACAAGGAGTTAACTATACGACC     
                                GATTTTGCCCACAAGGAGTTAACTATACGACCT     
                                 ATTTTGCCCACAAGGAGTTAACTATACGACCTT     
                                  TTTTGCCCACAAGGAGTTAACTATACGACCTTT     
                                   TTTGCCCACAAGGAGTTAACTATACGACCTGCT     
                                     TGCCCACAAGGAGTTAACTATACGACCTGCTGC   
                                      GCCCACAAGGAGTTAACTATACGACCTGCTGCC     
                                       CCCACAAGGAGTTAACTATACGACCTGCTGCCT     
                                        CCACAAGGAGTTAACTATACGACCTGCTGCCTT     
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Figure 4.4: Uridylation and degradation of diverse pre-miRNAs in P19 EC cells.  A) Pie charts representing the overall percentages of reads for each 
pre-miRNA: No Mod – reads aligning perfectly to any part of the loop or 3’ arm of the pre-miRNA; +U/+A/+G/+C – reads with a non-templated U, A, G or C 
(respectively) within the first 8nts of the sequence read (corresponding to within 8nts from the 3’ end of the cloned pre-miRNA).  B) Abundance of perfect reads 
(x-axis, left) and urdylated reads (x-axis, right) were plotted by position along the 3’ end of the pre-miRNA (y-axis); the yellow asterisk denotes reads that align 
perfectly to annotated 3’ end of the pre-miRNA.  C) Manual alignment of the most abundant reads in each position (“RM-seq reads”) against the annotated 
pre-miRNA sequence (“pre-miR”).
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cells after siRNA-mediated depletion of RRP40 which was previously shown to disrupt 3’-5’ 
exosome function (Preker et al., 2008). Indeed, when compared with a control knockdown 
using an siRNA to Luciferase (“Luc siRNA”), we observed an accumulation of uridylated 
sequence reads for many pre-miRNAs; the most drastic example of exosome-targeted 
pre-miRNAs were pre-miR-103-1 (Luc siRNA: 1080/15654 (6.9%) vs. RRP 40 siRNA: 
4837/7005 (69.1%)) and pre-miR-23a (Luc siRNA: 151/3241 (4.7%) vs. RRP40 siRNA: 
2578/5616 (45.9%), Figure 4.5A, B and C).  
 Other pre-miRNAs showed a robust accumulation of uridylated reads, including 
pre-miR-103-2 (Luc siRNA: 126/5582 (2.2%) vs. RRP40 siRNA 331/719 (46%)), pre-
miR-16-1 (Luc siRNA: 69/6447 (1.1%) vs. RRP40 siRNA: 671/7096 (9.5%)), pre-miR-16-2 
(Luc siRNA: 23/887 (2.6%) vs. RRP40 siRNA: 172/1723 (10.0%)) and pre-miR-302c (Luc 
siRNA: 235706/1221369 (19.3%) vs. RRP40 siRNA: 268299/873783 (30.7%).
Discussion:
 In this study, we devised a new method to look at pre-miRNA levels, 3’ end 
untemplated nucleotide addition and degradation.  Levels of let-7 pre-miRNAs and early 
embryonic pre-miRNAs largely correlated with corresponding mature miRNAs; this 
suggests that the post-transcriptional block of let-7 microRNAs does not occur solely at the 
point of Dicer processing.  Thus, the robust increase of many pre-let-7 miRNAs upon P19 
differentiation may be due to a transcriptional increase as well as a release of any block at 
the Drosha processing step.  Interestingly, different let-7 pre-miRNAs increase in strikingly 
different patterns.  For instance, pre-let-7a-1 increases less than 2-fold during the first 4 days 
of differentiation while pre-let-7a-2 increases ~1000-fold.  While the mechanism behind such 
differences aren’t known, it is clear that these two closely related pre-miRNAs regulated 
differently during cell differentiation.  
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Figure 4.5: Disruption of the 3’-5’ exosome pathway causes accumulation of uridylated pre-miRNAs.  A) Western blot for knockdown of RRP40; 
asterisk denotes a cross-reacting band on the anti-RRP40 blot that was used as a loading control.  B) Pie charts showing the overall percentages of 
perfectly-aligned versus reads with untemplated nucleotides.  C) Abundance of pre-miR-103-1 reads by position for cell transfected with a control siRNA 
versus cells transfected with an RRP40 siRNA.  D) Manual alignment of the most abundant RM-seq reads against the annotated pre-miRNA.
Figure 4.5: Disruption of the 3’-5’ exosome pathway causes accumulation of uridylated pre-miRNAs. A) 
Western blot for knockdown of RRP40; asterisk denotes a cross-reacting band on the anti-RRP40 blot that was 
used as a loading control. B) Pie charts showing the overall percentages of perfectly-aligned versus reads with 
untemplated nucleotides. C) Abundance of pre-miR-103-1 reads by position for cell transfected with a control 
siRNA versus cells transfected with an RRP40 siRNA. D) Manual alignment of the most abundant RM-seq 
reads against the annotated pre-miRNA.
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 We observed that pre-let-7d was acted upon by a processive uridylase activity in vivo, 
corroborating a previous report (Heo et al., 2008); however, it is still not known whether this 
oligo-U tail is reflective of the Lin28/TUT4 pathway or whether other TUTases are able to 
uridylated pre-let-7.  We found that it was difficult to knock down TUT4 consistently, as was 
previously reported (Heo et al., 2009).  Creation of transgenic TUT4 knockout mouse ES 
cells will be required to definitively answer this question.
 Surprisingly many other pre-miRNAs were significantly uridylated in P19 EC cells.  
For many of these pre-miRNAs, the corresponding mature miRNAs are post-transcriptionally 
repressed during murine embryonic development (Thomson et al., 2006).  Thus, it is possible 
that the post-transcriptional regulation of many miRNAs occurs, in part, through pre-miRNA 
uridylation and degradation.  Whether these pre-miRNAs are turned over by the Lin28/TUT4 
pathway is not known.  Lin28 binds to pre-miRNA loop sequences containing a GGAG 
motif (or close variations) and this motif must be precisely positioned within the pre-miRNA 
loop region in order for TUT4 uridylation to occur in vitro (Heo et al., 2009); however, this 
recognition site is absent from all of the uridylated non-let-7 pre-miRNAs that we observed.  
An especially unexpected observation is the extensive uridylation of miR-302c.  As miRNAs 
of the miR-302 family are highly expressed in these cells, it doesn’t seem likely that Lin28 
blocks pre-miR-302c processing.  We were also surprised to observe that many let-7 pre-
miRNAs were uridylated in differentiated P19 cells.  Taken together, this data points to a 
Lin28-independent pre-miRNA uridylation pathway in embryonic cells.
 We also observed a robust accumulation of uridylated pre-miRNAs upon the 
disruption of 3’-5’ exosome activity.  This is the first evidence that the exosome pathway is, 
in part, responsible for the turnover of uridylated pre-miRNAs.  Some pre-miRNAs showed 
a drastic increase in the percent of uridylated reads but a lower overall read count.  While it 
isn’t entirely clear why this occurred, we cannot rule out that the 5’-3’ exonucleases, Xrn-1 
and Xrn-2 also function in pre-miRNA degradation. It is possible that the partial ablation of 
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exosome activity leads to increased 5’-3’ degradation which would account for the decreased 
abundance of certain pre-miRNAs.
 It should be noted that we did not actively search for U-tails longer than 5nts; because 
our deep sequence reads were only 33nts, we couldn’t simultaneously search for longer 
U-tails and match sequence reads sufficiently to distinguish closely related pre-miRNAs.  
Thus, it is entirely possible that we cloned many pre-miRNAs with longer U-tails (such as 
let-7 pre-miRNAs with 10-30 U’s as was previously observed,  (Heo et al., 2008)) but could 
not successfully curate them due to the confined sequence space.  While we observed up to 
9 U’s on many partially-degraded pre-miRNAs (data not shown), these reads were relatively 
rare suggesting that a pre-miRNAs with this many U’s are highly unstable.
 It leads to reason that RM-seq has many potentially useful applications; while this 
study makes use of RNAi in mammalian cell culture, RM-seq would also be particularly 
powerful in model organisms that are much more amenable to genetic manipulation such as 
C. elegans (worms) and D. melanogaster (flies).  Of course, RM-seq could be employed to 
study the degradation and untemplated nucleotide addition of many other groups of RNAs 
such as (e.g.) small nuclear RNAs (snRNAs), tRNAs and groups of candidate mRNAs that 
may be turned over by uridylation (e.g. histone mRNAs).  
 Taken together, this data suggests that RM-seq can be a powerful tool for 
approximating fully intact pre-miRNAs levels as well as for the thorough analysis of pre-
miRNA degradation and uridylation on a much larger scale than is possible with conventional 
techniques for RNA detection.
Methods and Materials:
Cell Culture and transfection:  
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 P19 embryonic carcinoma (EC) cells were cultured, transfected with siRNAs and 
differentiated with all-trans retinoic acid (RA) as previously described (RNA paper); to 
enhance knockdown efficiency, P19 cells were transfect with siRNAs on three consecutive 
days.  Cells were harvested for RNA isolation 48 hours after the final transfection.  
RM-Seq cDNA library preparation:  
RNA preparation:
 P19 total RNA was obtained using Trizol.  High molecular weight (MW) RNA from 
50ug of total RNA was partially depleted by precipitation with 5% PEG
8000
 / 0.5M NaCl; the 
lower MW fraction was separated by electrophoresis on an 8% denaturing acrylamide/urea 
gel.  50-100nt RNA was isolated and eluted by incubation of gel slices overnight in 0.3M 
Sodium Acetate along with 50uL of phenol-chloroform.  Eluted RNA was then precipitated 
with 4uL of glycogen and an equal volume of isopropanol.  
RNA cloning linker and pre-adenylation:
 Cloning linker RNAs were purchased from IDT.  The RNAs contained 5’ phosphates, 
were blocked on the 3’ end by di-deoxy-cytidine and had the following sequences (barcodes 
are italicized and underlined; it should be noted that an oligo starting with the 5’ sequence 
“CCG…” was also purchased but failed to be pre-adenylated):
Barcode AAC:
5’ pGUUGAUCGUCGGACUGUAGAACUCUGAACddC 3’
Barcode TTC:
5’ pGAAGAUCGUCGGACUGUAGAACUCUGAACddC 3’
Barcode CCC:
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5’ pGGGGAUCGUCGGACUGUAGAACUCUGAACddC 3’
 Linkers were pre-adenylated as previously described with some modifications 
(Vigneault, Sismour, & Church, 2008).  800 pmols of RNA linker was incubated for 5 
hours at 37oC in a reaction containing 200 units of T4 RNA ligase I (New England Bio 
labs (NEB)), 1x RNA ligase I buffer [50mM Tris-HCl pH 7.8 / 10mM MgCl2 / 1mM ATP 
/ 10mM DTT], 4 units of Ribolock RNase A inhibitor (Fermentas) and 25% DMSO.  The 
RNA was then extracted with Phenol-Chloroform and electrophoresed on an 8% denaturing 
gel.  Adenylated RNA oligo (which migrates roughly 1-2 nucleotides higher than un-adylated 
oligo) was gel purified away from un-adenylated oligo and eluted as described above.  
Ligation, reverse transcription and PCR amplification:
 500ng of gel-purified RNA was ligated to 10 pmol pre-adenylated linker for 2 hours 
at 25oC in a reaction containing 200 units RNA ligase II, truncated (NEB), 1x PNK buffer 
[70mM Tris-HCl pH 7.6 / 1mM MgCl2 / 0.5 mM DTT] and 2 units of Ribolock.  RNA 
was then extracted with phenol-chloroform and precipitated with ethanol, 0.3M sodium 
acetate and 2uL glycogen.  Ligated RNA was reverse transcribed using the primer, 5’ 
GTTCAGAGTTCTACAGTCCGA 3’ and Superscript II reverse transcriptase (Invitrogen) 
according to the manufacturer’s instructions.  
The resulting cDNA was then amplified in two PCR reactions: 
miRNA-specific, 10 cycles: 4 uL of undiluted cDNA was 1) 
amplified with the Solexa small RNA forward primer, 5’ 
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 
3’ (2.5uM), a mixture of 42 reverse primers; these primers contained the Solexa 
small RNA reverse primer appended to the sense sequence of the 5’ arm of 42 
different miRNAs, 5’ CAAGCAGAAGACGGCATACGA[sense sequence 
of pre-microRNA 5’ arm] 3’ (1.25mM; see supplemental data for full list of 
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primer sequences) and Phusion DNA polymerase (Finnzymes) according to the 
manufacturer’s instructions.
Solexa primers only, 19 cycles:  1% of the first PCR reaction was amplified 2) 
with the forward primer above and the solexa small RNA reverse primer, 5’ 
CAAGCAGAAGACGGCATACGA 3’ and Phusion DNA polymerase.  
Thermo-cycling profile was as follows:  98oC for 30 seconds followed by cycles of 98oC for 
10 seconds, 59oC for 30 seconds and 72oC for 15 seconds.
PCR reactions were Phenol extracted and ethanol precipitated.  
High-throughput DNA sequencing and data analysis:
 36 nucleotide sequence reads were generated on the Solexa genome analyzer II 
(Illumina).  The data was then analyzed using custom scripts (S.M.H and M.A.N.).  Briefly, 
sequence reads were separated by barcode and the barcodes were removed.  
 Sequence reads that completely matched pre-miRNA sequences or contained non-
templated uridines (read as an “A” in the raw sequence) were annotated by their alignment to 
a particular position along a given pre-miRNA sequence using a “register” number.  Register 
numbers were established whereby the a register number of “1” aligned to the end of the pre-
microRNA and contained 6 additional nucleotides beyond the Drosha cleavage site (either 
matching sequences or, most often, containing non-templated nucleotides).
Pie charts were created in Microsoft Excel.  “Tornado” charts were created using i) 
Microsoft Excel.  Briefly, unmodified and uridylated sequence counts by register 
count in two separate bar graphs which were juxtaposed by dividing 1/X (where X = 
count of uridylated reads) and making the x-axis logarithmic.  Decimal values were 
converted to integers in Adobe Illustrator.
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cRT-PCR:
Analysis of 5’ and 3’ pre-miRNA ends was carried out as previously described (Basyuk et al., 
2003).  Briefly, total RNA was treated in a dilute RNA ligase I reaction on ice overnight to 
promote circularization of individual RNAs (200uL reaction volume containing 5ug RNA, 1x 
RNA ligase I buffer, 2 units of Ribolock and 20 units of RNA ligase I).  The ligated RNA was 
then phenol-chloroform extracted and 1ug was used in a conventional reverse transcription 
(RT) reaction using Superscript II.  The resulting RT reactions were diluted to 100uL and 
5uL was used per PCR reaction (25uL reaction containing 1x Titanium Taq buffer [40mM 
Tricine, pH 9.2 / 15mM KCl / 3.5mM MgCl2 / 3.75ug/mL BSA], 0.15mM dNTPs, 1.5 units 
of Hotstar Taq DNA polymerase (Qiagen) and 0.1uM primers).  The primers used were as 
follows:
Pre-let-7d-cRT CTCCTTGTGGGCAAAATC
Pre-let-7d-cRTPCR_F TCCTTGTGGGCAAAATCTCT
Pre-let-7d-cRTPCR_R TTAACTATACGACCTGCTGCCT
Pre-miR-103-1_cRT, CTTGATCCATATGCAACAAG
Pre-miR-103-1_cRTPCR_F, GCAACAAGGCAGCACTGTAA
Pre-miR-103-1_cRTPCR_R, CAGCATTGTACAGGGCTATG
Pre-miR-302c_cRT, TTGCTTTTGTTTAACACAGCA
Pre-miR-302c_cRTPCR_F, CACAGCAGGTAACCCCAT
Pre-miR-302c_cRTPCR_R, GTGCTTCCATGTTTCAGTG
Pre-miR-15b_cRT, CTGTAGTATGTAAACCATGATG
Pre-miR-15b_cRTPCR_F, ATGTAAACCATGATGTGCTGCT
Pre-miR-15b_cRTPCR_R, GCGAATCATTATTTGCTGCTC
Northern Blotting:
 20ug PEG-treated RNA was separated on a 12.5% denaturing urea-acrylamide gel 
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and transferred to a Hybond N+ nylon membrane (Amersham).  Membranes were hybridized 
overnight at 37oC with [P32] 5’-end labeled DNA probes of the following sequences: 5’ - 
ACT ATA CAA CCT ACT ACC TCA – 3’ (let-7a), 5’ – CCA CTG AAA CAT GGA AGC 
ACT TA – 3’ (miR-302c) and 5’ – TTC ACG AAT TTG CGT GTC AT -3’ (U6 snRNA).  
Membranes were then washed 3x at 37oC with 2xSSC / 0.05% SDS and 2x at 25oC with 
0.1x SSC / 0.1% SDS;
washed blots were then exposed to a phosphor-imaging screen and images were recorded on 
a Typhoon scanner (GE Life Sciences).  
Western blotting:  
 Control or RRP40 knockdown P19 cells were lysed in 2x loading buffer; proteins 
were then separated on a 12% SDS-Tris-Glycine Lamelli gel slab (???) and transferred to a 
Hybond ECL nitrocellulose membrane (GE Life Sciences).  The membrane was blotted with 
a rabbit polyclonal antibody to ExoSC3 (Abcam, catalog # ab76605) diluted 1:1000.
CHAPTER 5: 
Emerging paradigms of regulated microRNA processing and future directions1.
Summary:
Early studies by several labs found that mature miRNA expression does not always correlate 
with expression of the pri-miRNA (Blenkiron et al., 2007; Obernosterer et al., 2006; 
Thomson et al., 2006; Wulczyn et al., 2007).  Thus, miRNAs themselves must be post-
transcriptionally regulated.  In fact, regulation at multiple biogenesis steps and at turnover 
of the mature miRNA has now been established (Pawlicki & Steitz, 2010). The majority of 
discoveries on miRNA regulation can be distilled down to two contrasting paradigms based 
on the biochemical point of regulation:  at the Microprocessor complex and at the terminal 
loop of specific microRNA precursors.
Multiple regulatory events converge on the Microprocessor complex:
 As the first processing step in miRNA biogenesis, the Microprocessor is positioned 
to play a pivotal role in the regulation of mature microRNA abundance.  This complex is 
minimally composed of two proteins; the double stranded RNA binding protein DGCR8 
(Pasha) and the RNase III enzyme Drosha (Denli et al., 2004; Gregory et al., 2004; 
Landthaler, Yalcin, & Tuschl, 2004).  These two proteins represent the essential requirements 
for the first processing step, defined by reconstitution of activity with purified recombinant 
proteins.  In human cell extracts, however, Drosha has been described to reside in multiple 
1  Parts of this chapter are reprinted from Newman and Hammond, Genes Dev. 2010 
Jun 1;24(11):1086-92.
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complexes (Gregory et al., 2004).  A complex that is solely comprised of Drosha and 
DGCR8 has robust pri-miRNA processing activity.  A second, larger complex, has multiple 
accessory proteins, yet also has pri-miRNA processing activity.  It is not clear whether this 
large complex is assembled around RNAs, since many of the accessory factors contain 
RNA interaction motifs, and RNase treatment of extracts has been shown to shift the size 
of the Drosha complex (Han et al., 2004).  The accessory proteins in this large Drosha 
complex include the EWSR1, Fus, numerous hnRNP proteins, and the DEAD box helicases 
p68(DDX5) and p72(DDX17).  While the exact biochemical composition of the cellular 
Microprocessor is unknown, a recent collection of studies implicates p68 and p72 as 
important cofactors of the Microprocessor in vivo.
Integrating signal transduction with Drosha processing: the role of p68 and p72.
 The p68 and p72 helicases are conserved across eukaryotes and are implicated in 
diverse RNA processing pathways (Fuller-Pace, 2006).  In cell free assays, both proteins have 
moderately processive ATP dependent RNA unwinding and annealing activities.  In cells 
the proteins have been linked to several pathways, most notably splicing and transcription.  
p68 was isolated as a component of the spliceosome, and specifically is required for proper 
assembly-disassembly of the U1 5’ splice site.  Interestingly, p68 and p72 interact with 
several components of the transcriptional machinery, including RNA polymerase II and CBP/
p300.  This raises the interesting possibility that one role of p68 is to coordinate/co-localize 
the splicing machinery with the transcription apparatus.  Independent of this, p68 acts as 
a transcriptional cofactor for several factors, including CBP/p300, p53, and the Estrogen 
Receptor ERa.  For example, etoposide mediated induction of p53 responsive genes is 
dependent on p68.  Remarkably, this requirement is not dependent on p68 helicase activity, as 
an ATPase mutant allele of p68 rescued induction by p53.  RNA binding, however, was still 
required.  Similarly, ERa coactivation is not dependent on helicase activity.  This suggests 
a model whereby p68 and possibly p72 mediate assembly of transcription complexes at 
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promoters, recruit the splicing machinery to the promoter, thus facilitating co-transcriptional 
splicing events.  
 Recently, p68 and p72 were implicated as regulators of processing for many miRNAs 
(Fukuda et al., 2007).  This was first demonstrated in studies on mice that are homozygous 
null for either p68 or p72.  For both genes, loss of function is lethal; p68 null mice die at 
embryonic day 11.5, and p72 null mice are postnatal lethal.  miRNA expression analysis 
of null embryos indicated reduced mature miRNA levels.  Whether or not the reduction of 
these miRNAs was due to loss of function in the respective helicase, or whether the mutant 
phenotype led to aberrant miRNA expression due to developmental alterations, remains to 
be addressed.  However, fibroblasts (MEFs) derived from p72 null embryos had a reduction 
in at least two miRNAs (miR-16 and mir-145), but not all miRNAs, and this reduction 
could be rescued by introduction of ectopic p72.  Pri-miRNA expression was unaffected, 
demonstrating an alteration in processing of the miRNA precursors.  Interestingly, ATPase 
mutant alleles of p72 did not rescue production of either miR-16 or miR-145.  This is 
in contrast to the transcriptional co-activation role for p68, which was not dependent on 
helicase activity.  Therefore, for at least these two miRNAs, a role for helicase activity (or 
possibly ATP dependent conformation change) is required.  Furthermore, cell free extracts 
that lack either p68 or p72 are inefficient at conversion of pri-miR-16 to the corresponding 
precursor miRNA.  RNA immunoprecipitation (RIP) experiments in the same study showed 
that Drosha recruitment to pri-miR-199a and pri-miR-214 was lost upon RNAi-mediated 
depletion of p68 or in p72 knockout cells, consistent with the observation that mature 
miR-199a and miR-214 levels are lower in p68/p72 null embryos.  Thus, in vivo, these 
helicases seem to be required to properly recruit the Microprocessor to some pri-miRNAs.  
As discussed below, it is now clear that multiple critical cellular signaling pathways utilize 
the p68 and p72 association with Microprocessor to effect regulation of pri-microRNA 
processing.
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TGF-beta/BMP.
 The first study to report a signal transduction-mediated change in miRNA biogenesis 
demonstrated that the transforming growth factor (TGF-beta) and bone morphogenic protein 
(BMP) pathways specifically promote processing of pri-miR-21 (Davis et al., 2008).  The 
contractile phenotype of human smooth muscle cells treated with TGF-beta or BMP was 
found to be dependent on the rapid up-regulation of miR-21.  Interestingly, this rapid 
increase in miR-21 occurred post-transcriptionally; quantitative real-time PCR (qRT-PCR) 
experiments revealed that pre-miR-21 and mature miR-21 levels quickly increased upon 
TGF-beta and BMP treatment while levels of pri-miR-21 were unchanged.  The authors then 
reasoned that SMAD proteins might be the intermediaries responsible for connecting these 
signaling pathways with miR-21 processing as they are translocated into the nucleus upon 
TGF-beta or BMP signaling, and are known to bind DNA.  Furthermore, a previous study 
reported that SMAD1 interacts directly with the RNA helicase p68 (Warner et al., 2004).  
Accordingly, depletion of receptor-specific SMADs (SMAD1, SMAD5) or p68 abrogated 
the BMP and TGF-beta-driven increase in pri-miR-21 processing.  Some initial mechanistic 
insight was also provided; GST-pulldowns with recombinant SMADs in nuclear extracts 
indicated that p68 binds to the MH2 domain of R-SMADs while the MH1 domain binds to 
pri-miR-21 either directly or through other unknown factors.
 The full complement of miRNAs that are regulated by this pathway is presently 
unknown.  Since the TGF-beta and BMP signaling pathways regulate many biological 
phenomena, it is possible that these pathways stimulate processing of other pri-miRNAs; 
indeed the authors also observed that pri-miR-199a processing is regulated in this manner.  
This is not surprising, since these signaling pathways converge on miRNA processing via 
p68, and this helicase has been shown to modulate a number of miRNAs.  
The p53 DNA damage pathway.
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 Unexpectedly, a subsequent study demonstrated that the tumor suppressor p53 also 
promotes pri-miRNA processing.  It was noted that many microRNAs depleted in p72 
knockout mice, coincidentally, are also upregulated by the DNA damaging agent Doxorubicin 
(Dox).  As Dox strongly stimulates p53 activity, leading to induction of p53 responsive 
genes, it was perhaps not surprising that p53 might also induce the expression of miRNAs.  
In fact, miR-34 had been well established as a direct p53 transcriptional target (X. He, He, 
& Hannon, 2007).  However, after measuring pri-miRNA expression levels of induced 
miRNAs, the authors realized that these miRNAs were not being transcriptionally induced 
(Suzuki et al., 2009).  Rather, processing at the Drosha step was triggered.  In hindsight this 
was not so surprising: p68 was known to regulate pri-miRNA processing, and the helicase 
had been shown to interact with p53 as a co-activator; ergo, p53 might be able to directly 
modulate miRNA processing (Bates et al., 2005).  Accordingly, co-immunoprecipitation 
experiments as well as in vitro Drosha processing assays demonstrated that p53 associated 
with the large Drosha complex upon treatment of cells with Dox.  Intriguingly, p53 alleles 
with known oncogenic activity decreased processing efficiency of p53-targeted microRNAs 
by disrupting p68’s association with Drosha, thus displacing the Drosha complex selected 
pri-miRNAs.  Again, the biochemical basis of p53’s association with p68 and the subsequent 
increase in target pri-microRNA processing remains obscure.  Detailed structure-function 
studies will be needed to understand how p68 binding to p53 (both wildtype and oncogenic 
alleles) modulates Drosha’s ability to process pri-miRNAs.  
Estrogen receptor alpha/Estrogen.
 Another interesting report revealed how a signaling cascade can negatively regulate 
pri-miRNA processing.  Kato and colleagues noticed that ERa was previously shown to 
interact with p68 and p72 (Endoh et al., 1999).  Augmentation of the ERa signaling pathway 
produced a striking pattern of changes in certain microRNAs; many microRNAs were 
increased in ERa -/- mice (Yamagata et al., 2009).  Furthermore, administration of estradiol 
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(E2) to ovariectomized mice reduced the same miRNAs within the uterus.  Importantly, this 
effect of E2/ ERa could be recapitulated in the human breast cancer cell line MCF7.  The 
physiological importance of ERa-regulated microRNA biogenesis was evident from the 
observation that the 3’ untranslated region (3’ UTR) of VEGF, an ERa target gene, is targeted 
by ERa-repressed miRNAs.  The authors then demonstrated in vitro that E2-bound ERa could 
directly inhibit Drosha processing of ERa-target pri-microRNAs.  This study delved into 
more biochemical detail than the reports mentioned above:  it was determined that p68 and/
or p72 bridge the interaction between Drosha and E2-bound ERa; this interaction requires the 
C-terminal domain of Drosha and the N-terminus of ERa.  Thus, when ERa is recruited to the 
large Drosha complex in an E2-dependent manner, Drosha is dissociated from ERa-targeted 
pri-miRNA loci.  It will be interesting to determine whether ERa/E2 weakens the overall 
integrity of the large Drosha complex or simply its affinity for certain pri-miRNAs.  
A pri-miRNA processing holoenzyme?  Facts and future directions.
 As mentioned above, Drosha isolated from mammalian extracts exists in a large 
complex with many different RNA-binding proteins.  The role of most of these Drosha-
associated factors in pri-microRNA processing is not clear.  It seems entirely possible that 
many of the factors purified in the large cellular Drosha complex may be the result of a 
non-physiological RNA-protein complex assembled upon cell lysis. In support of this, while 
the dsRNA binding proteins NFAT-90 and NFAT-45 were previously shown to be Drosha 
associated factors (Gregory et al., 2004), one recent study showed that this heterodimer does 
not interact with Drosha and, in fact, inhibits processing of certain pri-microRNAs (Gregory 
et al., 2004; Sakamoto et al., 2009).  This study underscores the need to more carefully 
analyze the functional interactions between Drosha-DGCR8 and the many auxiliary factors 
that are contained within the large complex.  As with p68 and p72, there may indeed be 
important roles for other Drosha-associated factors, as general Microprocessor co-factors or 
as factors that integrate specific cell -signaling pathways with pri-miRNA processing.
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 So does Drosha/DGCR8 function within the context of a larger holoenzyme in 
vivo?  The studies mentioned above suggest that, of the Drosha-associated factors initially 
identified, p68 and p72 are the first to be assigned as important co-factors in Drosha 
processing of certain pri-microRNAs.  Taken together, the aforementioned studies suggest 
a model shown in Figure 5.1.  Drosha processing is known to occur co-transcriptionally 
(V. N. Kim, Han, & Siomi, 2009b).  p68 has been proposed to link mRNA transcription 
to splicing (Fuller-Pace & Ali, 2008).  Therefore, p68 and/or p72 might perform a similar 
function with miRNAs.  That is, p68 might act as a bridge between the Microprocessor and 
specific miRNAs, at the RNA polymerase holoenzyme during transcription.  This effect 
might be independent of helicase activity, as is the role of p68 in mRNA transcriptional 
events.  However, p72 activation of miR-16 and miR-145 processing is ATP dependent, 
suggesting a second, helicase dependent role for p72 (Fukuda et al., 2007).  This is further 
supported by the fact that p72 modulates Microprocessor function in cell free extracts, which 
is unlinked to transcription.  It is important to note that all these cell free assays are based on 
crude extracts or on partially purified components.  Without an exact understanding of the 
protein composition of the assays, it is difficult to fully understand the role of these accessory 
proteins.
II. It’s all in the loop: specific interactions between regulatory proteins and the terminal 
loop of microRNA precursors
As discussed above, one mode of regulated microRNA biogenesis occurs through modulation 
of Microprocessor activity.  A second regulatory phenomenon occurs when RNA binding 
proteins directly bind to specific sequences within pri-miRNAs, diverting the RNA away 
from biogenesis events, and often leading to degradation of the RNA.
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Figure 5.1.  Regulation of miRNA biogenesis at the Microprocessor.  Multiple signaling pathways 
converge on the Microprocessor via the helicases p68 and p72.  These helicases have ATP dependent and 
independent functions.  We present a model whereby both functions impinge on miRNA production.  The 
ATP independent functions have been linked with recruitment of processing activities to RNA polymerase.  
This could be utilized by the miRNA pathway, as a manner of recruitment of the Microprocessor to tran-
scription sites.  The ATP dependent role of p68 has been described as maintenance of proper RNA second-
ary structure to facilitate Drosha cleavage.  The components of the RNA polymerase preinitiation complex 
and Microprocessor are simplified.
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Lin28 as a master regulator of let-7 production.
 let-7 is one of the most abundant miRNA families in mammals, with high expression 
in essentially all adult tissues.  In embryonic cells, in contrast, mature let-7 is present 
at ~1000 fold lower levels.  Unexpectedly, pri-let-7 expression is constant throughout 
development, thus providing a dramatic illustration of post-transcriptional regulation 
of a miRNA (Thomson et al., 2006).  Research published over the past two years has 
demonstrated that the RNA binding protein Lin28 blocks let-7 microRNA maturation in early 
embryonic cells, and the related Lin28B contributes to let-7 reduction in cancer (reviewed 
in (Viswanathan & Daley, 2010)).  Initial studies demonstrated that Lin28 represses Drosha 
and Dicer processing of let-7 in vitro by binding to conserved sequences in the precursor 
loop.  Furthermore, over-expression of Lin28 in differentiated cells and knockdown of Lin28 
in embryonic cells resulted in the depletion and accumulation of mature let-7, respectively.  
The exact mechanism whereby Lin28 blocks processing steps is unknown.  What was clear is 
that the blocked pri-miRNA/pre-miRNA was not accumulating in cells, suggesting a turnover 
mechanism.  We now know, in the case of the pre-let-7, that Lin28 directly recruits a poly(U) 
polymerase, TUT4 to the precursor RNA (Heo, Joo, Kim, Ha, Yoon, Cho, Yeom, Han, & 
Kim, 2009a).  Oligo-uridylation of the precursor occurs, which triggers degradation.  The fate 
of the blocked pri-let-7 is still unknown (see Figure 5.2).  
 The story of Lin28 thus comes full circle.  This embryonic stem (ES) cell-specific 
RNA binding protein was one of the earliest-recognized let-7 targets (Reinhart et al., 2000).  
In embryonic development, its expression is reciprocal to that of mature let-7.  Concordantly, 
Lin28 over-expression, in combination with several ES-specific transcription factors, is 
sufficient to reprogram somatic cells into induced pluripotent stem (iPS) cells (Yu et al., 
2007).  
KSRP binds let-7 loop sequences and activates microRNA processing:
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 Recently, a role was uncovered for the RNA binding protein KSRP in promoting 
microRNA biogenesis in mammals (Trabucchi et al., 2009).  This protein specifically binds 
to 5’guanosine-rich patches on the loop region of several microRNA precursors, including 
let-7.  Knockdown of KSRP significantly decreases the expression of these miRNAs, in part 
by preventing efficient recruitment of Drosha and Dicer to the pri- and pre-microRNAs, 
respectively.  The obvious question is how can Lin28 and KSRP bind to the let-7 loop, but 
with opposing terminal outcomes?  Interestingly, while recombinant fragments of KSRP 
bind to the let-7 terminal loop with high affinity in vitro, KSRP cannot bind to pri-let-7 in 
embryonic cells, which have abundant Lin28.  This suggests a model whereby Lin28 and 
KSRP bind in a mutually exclusive manner.  Specifically, Lin28 may sterically hinder KSRP 
binding even thought the two proteins bind to unique sequences on opposites sides of the 
let-7 loop.  Alternatively, an unidentified factor in embryonic cells could bind cooperatively 
with Lin28 to let-7 loops, thereby preventing KSRP binding.
Regulation of microRNA processing by hnRNP proteins:
 While the above examples point to regulators with specific functions, there are other 
examples of RNA binding proteins with a pleiotropic function in RNA biogenesis.   One 
such example is the highly abundant RNA binding protein hnRNP A1.  This protein has been 
well established as a component of many heterogenous nuclear RNA complexes (hnRNP) 
and performs essential functions in many RNA processing and transport pathways (He and 
Smith 2009).  Using cross-linking immunoprecipitation (CLIP, (Guil & Caceres, 2007; Ule 
et al., 2005)).  This miRNA is one of six miRNA stem-loops on the oncogenic polycistron 
miR-17-92.  The role for hnRNP A1 in miRNA processing was demonstrated when HeLa 
extracts depleted of hnRNP A1 by RNAi failed to process pri-miR-18a from pri-miR-17-92 
while the other pri-miRNAs in the polycistron were still processed.  Interestingly, when 
recombinant hnRNP A1 was added back to the depleted extract, pri-miR-18a processing 
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was not restored; this suggests that hnRNP A1 might have to be “pre-complexed” with 
other RNA-binding factors in order to act specifically on pri-miR-18a.  Of course, it is also 
possible that bacterially purified hnRNP A1 is missing post-translational modifications that 
are required for the positive regulation of pri-miR-18a processing. 
 Further studies demonstrated that hnRNP A1 binding to the loop and stem regions 
of pri-miR-18a relaxes the stem region and facilitates cleavage by Drosha.  Bioinformatic 
analysis, RNA affinity purification using microRNA loop sequences as well as in vitro 
Drosha assays revealed that many hnRNP proteins could potentially form an extensive 
interaction network with microRNA loops (Michlewski, Guil, Semple, & Caceres, 2008).  
Thus, hnRNPs may broadly control the levels of microRNAs at the post-transcriptional level. 
The general physiological functions of hnRNP-microRNA loop interactions remain to be 
elucidated; ultimately, it will be important to understand the global distribution of hnRNP 
proteins between microRNAs and non-microRNA-containing substrates. 
III. Future directions:
Follow up RM-seq experiments:
 There are several outstanding questions from the intial RM-seq study.  First, where 
in the cell does the non-let-7 pre-miRNA uridylation occur?  Crude nuclear/cytoplasmic 
fractionation will reveal possible selective compartmentalization of the oligo-uridylation 
of certain pre-miRNAs.  Secondly, it is possible that uridylation of very abundant pre-
miRNAs (e.g. pre-miR-302c) is reflective of the saturation of miRNA biogenesis machinery; 
excess pre-miRNA substrate might be deferred to a turnover pathway in the nucleus and/
or cytoplasm.  This hypothesis is supported by an intriguing study showing that massively 
overexpressed artificial pre-miRNAs (as a vehicle for gene therapy) caused a broad reduction 
in mature miRNA expression due to inundation of nuclear export factor, Exportin-5 (Exp-5) 
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Figure 5.2.  Regulation of miRNA biogenesis by loop binding proteins.  The processing of let-7 is shown, with 
contrasting effects of an inhibitor (Lin28) and an activator (KSRP).  Both regulators have been linked to the Drosha and 
Dicer step.  In addition, Lin28 promotes degradation of the precursor.  Degradation of pri-let-7 has not been demon-
strated; however, pri-let-7 does not accumulate in the presence of Lin28 blockade, and therefore may be actively 
degraded.
(Grimm et al., 2006).   To test this possibility, we will deplete Exp-5 in P19 cells and analyze 
the overall degree of pre-miRNA uridylation in comparison to control cells.  If Exp-5 causes 
an increase in the uridylation of abundant pre-miRNAs this would suggest that one function 
of Lin28-independent uridyalation is to mark “unexportable” pre-miRNAs for turnover.  
 Because miRNAs are globally down regulated in poorly differentiated cancers, we 
will conduct a large-scale RM-seq project comparing the uridylation and degradation status 
of pre-miRNAs in poorly differentiated tumor samples versus non-cancerous adjacent tissue 
from UNC cancer patients.  If we do find that pre-miRNAs are globally uridylated in the 
cancer samples it might provide a major mechanistic insight in to how some of the most 
aggressive cancers seemingly regress into an undifferentiated state.  This could also lead to 
the development of diagnostic tools to characterize patient tumors; for example, it would 
be relatively simple to devise a rapid and efficient qRT-PCR protocol to detect any highly 
uridylated pre-miRNAs using a very small amount of RNA from a resected tumor.
 We have preliminary data indicating that knockdown of TUT4 causes a marked 
increase in the levels of pre-let-7 and a corresponding decrease in terminal uridylation, 
which was expected.  Surprisingly, knockdown of RRP40 revealed the same phenotype; 
this suggests the exciting possibility that the TUT4/Lin28/pre-let-7 complex might actually 
require the direct physical association of 3’-5’ exosome components for TUT4 uridylation 
of pre-let-7 to occur.  This raises the question: is there a Lin28/TUT4/Exosome-containing 
“holoenzyme” that selectively ensures the efficient turnover of let-7 pre-miRNAs?  To 
address this possibility we will knockdown other crucial components of the exosome and 
look for the same phenotype.  The goal would be to identify as many components of this 
putative “pre-let-7 degradosome” complex as possible.  We would eventually move in 
vitro assays using P19 cell extracts in order to biochemically purify a partial or complete 
degradosome complex.
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The unexplored potential of natural chemical modifications of small non-coding RNAs 
(ncRNAs) and the role of these modifications in ncRNA function:
 The best-known example of RNA modification in the RNAi field is the 
2’-O-methylation of piRNAs and (in plants) by the RNA methyltransferse HEN1.  This 
protects against uridylation and degradation (Li, Yang, Yu, Liu, & Chen, 2005).  
 I previously investigated the possibility that pre-let-7 might accumulate in cells based 
on previously published fluorescence in situ hybridizaiton (FISH) experiments  (Rybak et 
al., 2008) and that this accumulation might be due to 3’ end modification, thereby preventing 
turnover.  We attempted to follow the fate of pre-let-7 by Northern blotting total RNA from 
P19 cells after pre-treatment of the RNA with sodium periodate and alkaline Borax solution 
(Z. Yang et al., 2007) which results in the removal of the 3’ most nucleotide (and a slight 
downward shift) of any unmodified RNA by a beta-elimination reaction (that is, the 3’ most 
nucleotide has a hydroxyl moieties in the 2’ and 3’ positions).  While the strong pre-let-7-
sized band we observed was most likely an artifact caused by the cross-reaction of our locked 
nucleic acid (LNA) probe with one or more tRNAs (which are close in size to pre-let-7), it 
exhibited a strange behavior when subjected to beta-elimination: only a fraction on the pre-
let-7-sized band shifted downward; pre-treating by extraction with phenol, pH 8.0 causes 
a full shift downward.  In conclusion, we most likely witnessed the hydrolysis of one or 
more aminoacylted tRNAs, which are notoriously labile under even mild alkaline conditions 
(Stepanov & Nyborg, 2002); Trizol reagent, used for RNA islolation, contains acidified 
phenol (pH 4.0) does not have such a reactivity).  
 Regardless of the biochemical nature of this northern blot artifact, this series of 
studies peaked my interest in the possibility that there are many as-yet undiscovered chemical 
modifications of RNA and that this might have profound implications for the function of 
ncRNAs in vivo.  My interest was compounded by recent groundbreaking research carried 
out by David R. Liu and colleagues, who showed in an elegant series of mass spectrometry 
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experiments that many small RNAs (<200nts) are covalently linked on their 5’ end to small 
metabolites such as acetyl-CoA and NAD (Y. G. Chen et al., 2009; Kowtoniuk et al., 2009).  
This phenomenon was observed in bacteria, albeit two very divergent species.  Thus, it will 
be important to investigate whether these modified RNAs exist in eukaryotes.  I will persue 
this avenue of research in the laboratory of Dr. Gary Ruvkun at Harvard Medical School.  
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